Publication Results

Generate Report

Add publications by marking their checkboxes, or

Tobacco, alcohol, body mass index, physical activity, and the risk of head and neck cancer in the prostate, lung, colorectal, and ovarian (PLCO) cohort.

Hashibe M,  Hunt J,  Wei M,  Buys S,  Gren L,  Lee YC
Head Neck 2013 Jul;35(7):914-22
PubMed ID: 22711227
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Who should be included in a clinical trial of screening for bladder cancer?: a decision analysis of data from the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Vickers AJ,  Bennette C,  Kibel AS,  Black A,  Izmirlian G,  Stephenson AJ,  Bochner B
Cancer 2013 Jan 1;119(1):143-9
PubMed ID: 22736219
PMC ID: PMC4036636
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Non-steroidal anti-inflammatory drug use and the risk of benign prostatic hyperplasia-related outcomes and nocturia in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Sutcliffe S,  Grubb Iii RL,  Platz EA,  Ragard LR,  Riley TL,  Kazin SS,  Hayes RB,  Hsing AW,  Andriole GL,  Urologic Diseases in America Project
BJU Int 2012 Oct;110(7):1050-9
PubMed ID: 22429766
PMC ID: PMC3382045
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Long-term disease-specific functioning among prostate cancer survivors and noncancer controls in the prostate, lung, colorectal, and ovarian cancer screening trial.

Taylor KL,  Luta G,  Miller AB,  Church TR,  Kelly SP,  Muenz LR,  Davis KM,  Dawson DL,  Edmond S,  Reding D,  Mabie JE,  Riley TL
J Clin Oncol 2012 Aug 1;30(22):2768-75
PubMed ID: 22734029
PMC ID: PMC4166119
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Factors associated with inadequate colorectal cancer screening with flexible sigmoidoscopy.

Laiyemo AO,  Doubeni C,  Pinsky PF,  Doria-Rose VP,  Sanderson AK 2nd,  Bresalier R,  Weissfeld J,  Schoen RE,  Marcus PM,  Prorok PC,  Berg CD
Cancer Epidemiol 2012 Aug;36(4):395-9
PubMed ID: 22112544
PMC ID: PMC3288883
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Serum IGF1, IGF2 and IGFBP3 and risk of advanced colorectal adenoma.

Gao Y,  Katki H,  Graubard B,  Pollak M,  Martin M,  Tao Y,  Schoen RE,  Church T,  Hayes RB,  Greene MH,  Berndt SI
Int J Cancer 2012 Jul 15;131(2):E105-13
PubMed ID: 21932422
PMC ID: PMC3288254
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Assessing disease risk in genome-wide association studies using family history.

Ghosh A,  Hartge P,  Purdue MP,  Chanock SJ,  Amundadottir L,  Wang Z,  Wentzensen N,  Chatterjee N,  Wacholder S
Epidemiology 2012 Jul;23(4):616-22
PubMed ID: 22575968
PMC ID: PMC3371359
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Tracking and tracing of participants in two large cancer screening trials.

Marcus PM,  Childs J,  Gahagan B,  Gren LH
Contemp Clin Trials 2012 Jul;33(4):601-5
PubMed ID: 22561392
PMC ID: PMC3361574
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Serum vitamin D and risk of bladder cancer in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening trial.

Mondul AM,  Weinstein SJ,  Horst RL,  Purdue M,  Albanes D
Cancer Epidemiol Biomarkers Prev 2012 Jul;21(7):1222-5
PubMed ID: 22623707
PMC ID: PMC3392360
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Aspirin but not ibuprofen use is associated with reduced risk of prostate cancer: a PLCO study.

Shebl FM,  Sakoda LC,  Black A,  Koshiol J,  Andriole GL,  Grubb R,  Church TR,  Chia D,  Zhou C,  Chu LW,  Huang WY,  Peters U,  Kirsh VA,  Chatterjee N,  Leitzmann MF,  Hayes RB,  Hsing AW
Br J Cancer 2012 Jun 26;107(1):207-14
PubMed ID: 22722313
PMC ID: PMC3389420
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Alcohol, genetics and risk of breast cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

McCarty CA,  Reding DJ,  Commins J,  Williams C,  Yeager M,  Burmester JK,  Schairer C,  Ziegler RG
Breast Cancer Res Treat 2012 Jun;133(2):785-92
PubMed ID: 22331481
PMC ID: PMC3584637
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Characterization of gene-environment interactions for colorectal cancer susceptibility loci.

Hutter CM,  Chang-Claude J,  Slattery ML,  Pflugeisen BM,  Lin Y,  Duggan D,  Nan H,  Lemire M,  Rangrej J,  Figueiredo JC,  Jiao S,  Harrison TA,  Liu Y,  Chen LS,  Stelling DL,  Warnick GS,  Hoffmeister M,  Küry S,  Fuchs CS,  Giovannucci E,  Hazra A,  Kraft P,  Hunter DJ,  Gallinger S,  Zanke BW,  Brenner H,  Frank B,  Ma J,  Ulrich CM,  White E,  Newcomb PA,  Kooperberg C,  LaCroix AZ,  Prentice RL,  Jackson RD,  Schoen RE,  Chanock SJ,  Berndt SI,  Hayes RB,  Caan BJ,  Potter JD,  Hsu L,  Bézieau S,  Chan AT,  Hudson TJ,  Peters U
Cancer Res 2012 Apr 15;72(8):2036-44
PubMed ID: 22367214
PMC ID: PMC3374720
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Longitudinal evaluation of CA-125 velocity and prediction of ovarian cancer.

Xu JL,  Commins J,  Partridge E,  Riley TL,  Prorok PC,  Johnson CC,  Buys SS
Gynecol Oncol 2012 Apr;125(1):70-4
PubMed ID: 22198243
PMC ID: PMC3303942
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Associations between genes in the one-carbon metabolism pathway and advanced colorectal adenoma risk in individuals with low folate intake.

Han SS,  Sue LY,  Berndt SI,  Selhub J,  Burdette LA,  Rosenberg PS,  Ziegler RG
Cancer Epidemiol Biomarkers Prev 2012 Mar;21(3):417-27
PubMed ID: 22253295
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Fine mapping of 14q24.1 breast cancer susceptibility locus.

Lee P,  Fu YP,  Figueroa JD,  Prokunina-Olsson L,  Gonzalez-Bosquet J,  Kraft P,  Wang Z,  Jacobs KB,  Yeager M,  Horner MJ,  Hankinson SE,  Hutchinson A,  Chatterjee N,  Garcia-Closas M,  Ziegler RG,  Berg CD,  Buys SS,  McCarty CA,  Feigelson HS,  Thun MJ,  Diver R,  Prentice R,  Jackson R,  Kooperberg C,  Chlebowski R,  Lissowska J,  Peplonska B,  Brinton LA,  Tucker M,  Fraumeni JF Jr,  Hoover RN,  Thomas G,  Hunter DJ,  Chanock SJ
Hum Genet 2012 Mar;131(3):479-90
PubMed ID: 21959381
PMC ID: PMC4159746
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Colorectal cancers not detected by screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Schoen RE,  Pinsky PF,  Weissfeld JL,  Yokochi LA,  Church T,  Laiyemo AO,  Bresalier R,  Hickey T,  Riley T,  Prorok PC
Gastrointest Endosc 2012 Mar;75(3):612-20
PubMed ID: 22341106
PMC ID: not available
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Estrogen metabolism and risk of breast cancer in postmenopausal women.

Fuhrman BJ,  Schairer C,  Gail MH,  Boyd-Morin J,  Xu X,  Sue LY,  Buys SS,  Isaacs C,  Keefer LK,  Veenstra TD,  Berg CD,  Hoover RN,  Ziegler RG
J Natl Cancer Inst 2012 Feb 22;104(4):326-39
PubMed ID: 22232133
PMC ID: PMC3283536
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Flexible sigmoidoscopy in the randomized prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: added yield from a second screening examination.

Weissfeld JL,  Schoen RE,  Pinsky PF,  Bresalier RS,  Doria-Rose VP,  Laiyemo AO,  Church T,  Yokochi LA,  Yurgalevitch S,  Rathmell J,  Andriole GL,  Buys S,  Crawford ED,  Fouad M,  Isaacs C,  Lamerato L,  Reding D,  Prorok PC,  Berg CD,  PLCO Project Team
J Natl Cancer Inst 2012 Feb 22;104(4):280-9
PubMed ID: 22298838
PMC ID: PMC3283538
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Meta-analysis of new genome-wide association studies of colorectal cancer risk.

Peters U,  Hutter CM,  Hsu L,  Schumacher FR,  Conti DV,  Carlson CS,  Edlund CK,  Haile RW,  Gallinger S,  Zanke BW,  Lemire M,  Rangrej J,  Vijayaraghavan R,  Chan AT,  Hazra A,  Hunter DJ,  Ma J,  Fuchs CS,  Giovannucci EL,  Kraft P,  Liu Y,  Chen L,  Jiao S,  Makar KW,  Taverna D,  Gruber SB,  Rennert G,  Moreno V,  Ulrich CM,  Woods MO,  Green RC,  Parfrey PS,  Prentice RL,  Kooperberg C,  Jackson RD,  Lacroix AZ,  Caan BJ,  Hayes RB,  Berndt SI,  Chanock SJ,  Schoen RE,  Chang-Claude J,  Hoffmeister M,  Brenner H,  Frank B,  Bézieau S,  Küry S,  Slattery ML,  Hopper JL,  Jenkins MA,  Le Marchand L,  Lindor NM,  Newcomb PA,  Seminara D,  Hudson TJ,  Duggan DJ,  Potter JD,  Casey G
Hum Genet 2012 Feb;131(2):217-34
PubMed ID: 21761138
PMC ID: PMC3257356
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Prostate cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial: mortality results after 13 years of follow-up.

Andriole GL,  Crawford ED,  Grubb RL 3rd,  Buys SS,  Chia D,  Church TR,  Fouad MN,  Isaacs C,  Kvale PA,  Reding DJ,  Weissfeld JL,  Yokochi LA,  O'Brien B,  Ragard LR,  Clapp JD,  Rathmell JM,  Riley TL,  Hsing AW,  Izmirlian G,  Pinsky PF,  Kramer BS,  Miller AB,  Gohagan JK,  Prorok PC,  PLCO Project Team
J Natl Cancer Inst 2012 Jan 18;104(2):125-32
PubMed ID: 22228146
PMC ID: PMC3260132
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Proteomic biomarkers in combination with CA 125 for detection of epithelial ovarian cancer using prediagnostic serum samples from the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.

Moore LE,  Pfeiffer RM,  Zhang Z,  Lu KH,  Fung ET,  Bast RC Jr
Cancer 2012 Jan 1;118(1):91-100
PubMed ID: 21717433
PMC ID: PMC3385508
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Pancreatic cancer risk: associations with meat-derived carcinogen intake in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort.

Anderson KE,  Mongin SJ,  Sinha R,  Stolzenberg-Solomon R,  Gross MD,  Ziegler RG,  Mabie JE,  Risch A,  Kazin SS,  Church TR
Mol Carcinog 2012 Jan;51(1):128-37
PubMed ID: 22162237
PMC ID: PMC3516181
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

The association between inflammation-related genes and serum androgen levels in men: the prostate, lung, colorectal, and ovarian study.

Meyer TE,  Chu LW,  Li Q,  Yu K,  Rosenberg PS,  Menashe I,  Chokkalingam AP,  Quraishi SM,  Huang WY,  Weiss JM,  Kaaks R,  Hayes RB,  Chanock SJ,  Hsing AW
Prostate 2012 Jan;72(1):65-71
PubMed ID: 21520164
PMC ID: PMC3156884
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Serum α-tocopherol and γ-tocopherol concentrations and prostate cancer risk in the PLCO Screening Trial: a nested case-control study.

Weinstein SJ,  Peters U,  Ahn J,  Friesen MD,  Riboli E,  Hayes RB,  Albanes D
PLoS One 2012;7(7):e40204
PubMed ID: 22792240
PMC ID: PMC3390343
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

N-acetyltransferase 2 polymorphisms, tobacco smoking, and breast cancer risk in the breast and prostate cancer cohort consortium.

Cox DG,  Dostal L,  Hunter DJ,  Le Marchand L,  Hoover R,  Ziegler RG,  Thun MJ,  Breast and Prostate Cancer Cohort Consortium
Am J Epidemiol 2011 Dec 1;174(11):1316-22
PubMed ID: 22074863
PMC ID: PMC3390163
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Genome-wide association study of circulating retinol levels.

Mondul AM,  Yu K,  Wheeler W,  Zhang H,  Weinstein SJ,  Major JM,  Cornelis MC,  Männistö S,  Hazra A,  Hsing AW,  Jacobs KB,  Eliassen H,  Tanaka T,  Reding DJ,  Hendrickson S,  Ferrucci L,  Virtamo J,  Hunter DJ,  Chanock SJ,  Kraft P,  Albanes D
Hum Mol Genet 2011 Dec 1;20(23):4724-31
PubMed ID: 21878437
PMC ID: PMC3209826
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Prostate-specific antigen 1.5-4.0 ng/mL: a diagnostic challenge and danger zone.

Crawford ED,  Moul JW,  Rove KO,  Pettaway CA,  Lamerato LE,  Hughes A
BJU Int 2011 Dec;108(11):1743-9
PubMed ID: 21711431
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Screening by chest radiograph and lung cancer mortality: the Prostate, Lung, Colorectal, and Ovarian (PLCO) randomized trial.

Oken MM,  Hocking WG,  Kvale PA,  Andriole GL,  Buys SS,  Church TR,  Crawford ED,  Fouad MN,  Isaacs C,  Reding DJ,  Weissfeld JL,  Yokochi LA,  O'Brien B,  Ragard LR,  Rathmell JM,  Riley TL,  Wright P,  Caparaso N,  Hu P,  Izmirlian G,  Pinsky PF,  Prorok PC,  Kramer BS,  Miller AB,  Gohagan JK,  Berg CD,  PLCO Project Team
JAMA 2011 Nov 2;306(17):1865-73
PubMed ID: 22031728
PMC ID: not available
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Potential role of HE4 in multimodal screening for epithelial ovarian cancer.

Urban N,  Thorpe JD,  Bergan LA,  Forrest RM,  Kampani AV,  Scholler N,  O'Briant KC,  Anderson GL,  Cramer DW,  Berg CD,  McIntosh MW,  Hartge P,  Drescher CW
J Natl Cancer Inst 2011 Nov 2;103(21):1630-4
PubMed ID: 21917606
PMC ID: PMC3206037
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Intra-individual variability over time in serum cytokine levels among participants in the prostate, lung, colorectal, and ovarian cancer screening Trial.

Hofmann JN,  Yu K,  Bagni RK,  Lan Q,  Rothman N,  Purdue MP
Cytokine 2011 Nov;56(2):145-8
PubMed ID: 21764327
PMC ID: PMC3185107
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

The use of imputed values in the meta-analysis of genome-wide association studies.

Jiao S,  Hsu L,  Hutter CM,  Peters U
Genet Epidemiol 2011 Nov;35(7):597-605
PubMed ID: 21769935
PMC ID: PMC3201718
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Genome-wide association study identifies new prostate cancer susceptibility loci.

Schumacher FR,  Berndt SI,  Siddiq A,  Jacobs KB,  Wang Z,  Lindstrom S,  Stevens VL,  Chen C,  Mondul AM,  Travis RC,  Stram DO,  Eeles RA,  Easton DF,  Giles G,  Hopper JL,  Neal DE,  Hamdy FC,  Donovan JL,  Muir K,  Al Olama AA,  Kote-Jarai Z,  Guy M,  Severi G,  Grönberg H,  Isaacs WB,  Karlsson R,  Wiklund F,  Xu J,  Allen NE,  Andriole GL,  Barricarte A,  Boeing H,  Bueno-de-Mesquita HB,  Crawford ED,  Diver WR,  Gonzalez CA,  Gaziano JM,  Giovannucci EL,  Johansson M,  Le Marchand L,  Ma J,  Sieri S,  Stattin P,  Stampfer MJ,  Tjonneland A,  Vineis P,  Virtamo J,  Vogel U,  Weinstein SJ,  Yeager M,  Thun MJ,  Kolonel LN,  Henderson BE,  Albanes D,  Hayes RB,  Feigelson HS,  Riboli E,  Hunter DJ,  Chanock SJ,  Haiman CA,  Kraft P
Hum Mol Genet 2011 Oct 1;20(19):3867-75
PubMed ID: 21743057
PMC ID: PMC3168287
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Identification, replication, and fine-mapping of Loci associated with adult height in individuals of african ancestry.

N'Diaye A,  Chen GK,  Palmer CD,  Ge B,  Tayo B,  Mathias RA,  Ding J,  Nalls MA,  Adeyemo A,  Adoue V,  Ambrosone CB,  Atwood L,  Bandera EV,  Becker LC,  Berndt SI,  Bernstein L,  Blot WJ,  Boerwinkle E,  Britton A,  Casey G,  Chanock SJ,  Demerath E,  Deming SL,  Diver WR,  Fox C,  Harris TB,  Hernandez DG,  Hu JJ,  Ingles SA,  John EM,  Johnson C,  Keating B,  Kittles RA,  Kolonel LN,  Kritchevsky SB,  Le Marchand L,  Lohman K,  Liu J,  Millikan RC,  Murphy A,  Musani S,  Neslund-Dudas C,  North KE,  Nyante S,  Ogunniyi A,  Ostrander EA,  Papanicolaou G,  Patel S,  Pettaway CA,  Press MF,  Redline S,  Rodriguez-Gil JL,  Rotimi C,  Rybicki BA,  Salako B,  Schreiner PJ,  Signorello LB,  Singleton AB,  Stanford JL,  Stram AH,  Stram DO,  Strom SS,  Suktitipat B,  Thun MJ,  Witte JS,  Yanek LR,  Ziegler RG,  Zheng W,  Zhu X,  Zmuda JM,  Zonderman AB,  Evans MK,  Liu Y,  Becker DM,  Cooper RS,  Pastinen T,  Henderson BE,  Hirschhorn JN,  Lettre G,  Haiman CA
PLoS Genet 2011 Oct;7(10):e1002298
PubMed ID: 21998595
PMC ID: PMC3188544
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Circulating markers of interstitial lung disease and subsequent risk of lung cancer.

Shiels MS,  Chaturvedi AK,  Katki HA,  Gochuico BR,  Caporaso NE,  Engels EA
Cancer Epidemiol Biomarkers Prev 2011 Oct;20(10):2262-72
PubMed ID: 21828236
PMC ID: PMC3189337
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Iron homeostasis and distal colorectal adenoma risk in the prostate, lung, colorectal, and ovarian cancer screening trial.

Cross AJ,  Sinha R,  Wood RJ,  Xue X,  Huang WY,  Yeager M,  Hayes RB,  Gunter MJ
Cancer Prev Res (Phila) 2011 Sep;4(9):1465-75
PubMed ID: 21685236
PMC ID: PMC3168068
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Interactions between genetic variants and breast cancer risk factors in the breast and prostate cancer cohort consortium.

Campa D,  Kaaks R,  Le Marchand L,  Haiman CA,  Travis RC,  Berg CD,  Buring JE,  Chanock SJ,  Diver WR,  Dostal L,  Fournier A,  Hankinson SE,  Henderson BE,  Hoover RN,  Isaacs C,  Johansson M,  Kolonel LN,  Kraft P,  Lee IM,  McCarty CA,  Overvad K,  Panico S,  Peeters PH,  Riboli E,  Sanchez MJ,  Schumacher FR,  Skeie G,  Stram DO,  Thun MJ,  Trichopoulos D,  Zhang S,  Ziegler RG,  Hunter DJ,  Lindström S,  Canzian F
J Natl Cancer Inst 2011 Aug 17;103(16):1252-63
PubMed ID: 21791674
PMC ID: PMC3156803
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Large-scale fine mapping of the HNF1B locus and prostate cancer risk.

Berndt SI,  Sampson J,  Yeager M,  Jacobs KB,  Wang Z,  Hutchinson A,  Chung C,  Orr N,  Wacholder S,  Chatterjee N,  Yu K,  Kraft P,  Feigelson HS,  Thun MJ,  Diver WR,  Albanes D,  Virtamo J,  Weinstein S,  Schumacher FR,  Cancel-Tassin G,  Cussenot O,  Valeri A,  Andriole GL,  Crawford ED,  Haiman C,  Henderson B,  Kolonel L,  Le Marchand L,  Siddiq A,  Riboli E,  Travis RC,  Kaaks R,  Isaacs W,  Isaacs S,  Wiley KE,  Gronberg H,  Wiklund F,  Stattin P,  Xu J,  Zheng SL,  Sun J,  Vatten LJ,  Hveem K,  Njølstad I,  Gerhard DS,  Tucker M,  Hayes RB,  Hoover RN,  Fraumeni JF Jr,  Hunter DJ,  Thomas G,  Chanock SJ
Hum Mol Genet 2011 Aug 15;20(16):3322-9
PubMed ID: 21576123
PMC ID: PMC3140817
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Diabetes prevalence is associated with serum 25-hydroxyvitamin D and 1,25-dihydroxyvitamin D in US middle-aged Caucasian men and women: a cross-sectional analysis within the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Brock KE,  Huang WY,  Fraser DR,  Ke L,  Tseng M,  Mason RS,  Stolzenberg-Solomon RZ,  Freedman DM,  Ahn J,  Peters U,  McCarty C,  Hollis BW,  Ziegler RG,  Purdue MP,  Graubard BI
Br J Nutr 2011 Aug;106(3):339-44
PubMed ID: 21736838
PMC ID: PMC3515777
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Likelihood of missed and recurrent adenomas in the proximal versus the distal colon.

Laiyemo AO,  Doubeni C,  Sanderson AK 2nd,  Pinsky PF,  Badurdeen DS,  Doria-Rose VP,  Marcus PM,  Schoen RE,  Lanza E,  Schatzkin A,  Cross AJ
Gastrointest Endosc 2011 Aug;74(2):253-61
PubMed ID: 21549375
PMC ID: PMC3148340
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

The landscape of recombination in African Americans.

Hinch AG,  Tandon A,  Patterson N,  Song Y,  Rohland N,  Palmer CD,  Chen GK,  Wang K,  Buxbaum SG,  Akylbekova EL,  Aldrich MC,  Ambrosone CB,  Amos C,  Bandera EV,  Berndt SI,  Bernstein L,  Blot WJ,  Bock CH,  Boerwinkle E,  Cai Q,  Caporaso N,  Casey G,  Cupples LA,  Deming SL,  Diver WR,  Divers J,  Fornage M,  Gillanders EM,  Glessner J,  Harris CC,  Hu JJ,  Ingles SA,  Isaacs W,  John EM,  Kao WH,  Keating B,  Kittles RA,  Kolonel LN,  Larkin E,  Le Marchand L,  McNeill LH,  Millikan RC,  Murphy A,  Musani S,  Neslund-Dudas C,  Nyante S,  Papanicolaou GJ,  Press MF,  Psaty BM,  Reiner AP,  Rich SS,  Rodriguez-Gil JL,  Rotter JI,  Rybicki BA,  Schwartz AG,  Signorello LB,  Spitz M,  Strom SS,  Thun MJ,  Tucker MA,  Wang Z,  Wiencke JK,  Witte JS,  Wrensch M,  Wu X,  Yamamura Y,  Zanetti KA,  Zheng W,  Ziegler RG,  Zhu X,  Redline S,  Hirschhorn JN,  Henderson BE,  Taylor HA Jr,  Price AL,  Hakonarson H,  Chanock SJ,  Haiman CA,  Wilson JG,  Reich D,  Myers SR
Nature 2011 Jul 20;476(7359):170-5
PubMed ID: 21775986
PMC ID: PMC3154982
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Increased levels of circulating interleukin 6, interleukin 8, C-reactive protein, and risk of lung cancer.

Pine SR,  Mechanic LE,  Enewold L,  Chaturvedi AK,  Katki HA,  Zheng YL,  Bowman ED,  Engels EA,  Caporaso NE,  Harris CC
J Natl Cancer Inst 2011 Jul 20;103(14):1112-22
PubMed ID: 21685357
PMC ID: PMC3139587
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Prediagnostic serum levels of cytokines and other immune markers and risk of non-hodgkin lymphoma.

Purdue MP,  Lan Q,  Bagni R,  Hocking WG,  Baris D,  Reding DJ,  Rothman N
Cancer Res 2011 Jul 15;71(14):4898-907
PubMed ID: 21632552
PMC ID: PMC3138883
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Seven prostate cancer susceptibility loci identified by a multi-stage genome-wide association study.

Kote-Jarai Z,  Olama AA,  Giles GG,  Severi G,  Schleutker J,  Weischer M,  Campa D,  Riboli E,  Key T,  Gronberg H,  Hunter DJ,  Kraft P,  Thun MJ,  Ingles S,  Chanock S,  Albanes D,  Hayes RB,  Neal DE,  Hamdy FC,  Donovan JL,  Pharoah P,  Schumacher F,  Henderson BE,  Stanford JL,  Ostrander EA,  Sorensen KD,  Dörk T,  Andriole G,  Dickinson JL,  Cybulski C,  Lubinski J,  Spurdle A,  Clements JA,  Chambers S,  Aitken J,  Gardiner RA,  Thibodeau SN,  Schaid D,  John EM,  Maier C,  Vogel W,  Cooney KA,  Park JY,  Cannon-Albright L,  Brenner H,  Habuchi T,  Zhang HW,  Lu YJ,  Kaneva R,  Muir K,  Benlloch S,  Leongamornlert DA,  Saunders EJ,  Tymrakiewicz M,  Mahmud N,  Guy M,  O'Brien LT,  Wilkinson RA,  Hall AL,  Sawyer EJ,  Dadaev T,  Morrison J,  Dearnaley DP,  Horwich A,  Huddart RA,  Khoo VS,  Parker CC,  Van As N,  Woodhouse CJ,  Thompson A,  Christmas T,  Ogden C,  Cooper CS,  Lophatonanon A,  Southey MC,  Hopper JL,  English DR,  Wahlfors T,  Tammela TL,  Klarskov P,  Nordestgaard BG,  Røder MA,  Tybjærg-Hansen A,  Bojesen SE,  Travis R,  Canzian F,  Kaaks R,  Wiklund F,  Aly M,  Lindstrom S,  Diver WR,  Gapstur S,  Stern MC,  Corral R,  Virtamo J,  Cox A,  Haiman CA,  Le Marchand L,  Fitzgerald L,  Kolb S,  Kwon EM,  Karyadi DM,  Orntoft TF,  Borre M,  Meyer A,  Serth J,  Yeager M,  Berndt SI,  Marthick JR,  Patterson B,  Wokolorczyk D,  Batra J,  Lose F,  McDonnell SK,  Joshi AD,  Shahabi A,  Rinckleb AE,  Ray A,  Sellers TA,  Lin HY,  Stephenson RA,  Farnham J,  Muller H,  Rothenbacher D,  Tsuchiya N,  Narita S,  Cao GW,  Slavov C,  Mitev V,  Easton DF,  Eeles RA,  UK Genetic Prostate Cancer Study Collaborators/British Association of Urological Surgeons' Section of Oncology,  UK ProtecT Study Collaborators, The Australian Prostate Cancer BioResource,  PRACTICAL Consortium
Nat Genet 2011 Jul 10;43(8):785-91
PubMed ID: 21743467
PMC ID: PMC3396006
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Lung cancer risk prediction: Prostate, Lung, Colorectal And Ovarian Cancer Screening Trial models and validation.

Tammemagi CM,  Pinsky PF,  Caporaso NE,  Kvale PA,  Hocking WG,  Church TR,  Riley TL,  Commins J,  Oken MM,  Berg CD,  Prorok PC
J Natl Cancer Inst 2011 Jul 6;103(13):1058-68
PubMed ID: 21606442
PMC ID: PMC3131220
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Dietary carbohydrate, glycemic index, glycemic load, and risk of prostate cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort.

Shikany JM,  Flood AP,  Kitahara CM,  Hsing AW,  Meyer TE,  Willcox BJ,  Redden DT,  Ziegler RG
Cancer Causes Control 2011 Jul;22(7):995-1002
PubMed ID: 21553078
PMC ID: PMC4470253
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Effect of screening on ovarian cancer mortality: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Randomized Controlled Trial.

Buys SS,  Partridge E,  Black A,  Johnson CC,  Lamerato L,  Isaacs C,  Reding DJ,  Greenlee RT,  Yokochi LA,  Kessel B,  Crawford ED,  Church TR,  Andriole GL,  Weissfeld JL,  Fouad MN,  Chia D,  O'Brien B,  Ragard LR,  Clapp JD,  Rathmell JM,  Riley TL,  Hartge P,  Pinsky PF,  Zhu CS,  Izmirlian G,  Kramer BS,  Miller AB,  Xu JL,  Prorok PC,  Gohagan JK,  Berg CD,  PLCO Project Team
JAMA 2011 Jun 8;305(22):2295-303
PubMed ID: 21642681
PMC ID: not available
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial: the prostate cancer screening results in context.

Berg CD
Acta Oncol 2011 Jun;50 Suppl 1:12-7
PubMed ID: 21604935
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

DNA repair gene polymorphisms and tobacco smoking in the risk for colorectal adenomas.

Gao Y,  Hayes RB,  Huang WY,  Caporaso NE,  Burdette L,  Yeager M,  Chanock SJ,  Berndt SI
Carcinogenesis 2011 Jun;32(6):882-7
PubMed ID: 21504893
PMC ID: PMC3106441
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Genome-wide association study of prostate cancer in men of African ancestry identifies a susceptibility locus at 17q21.

Haiman CA,  Chen GK,  Blot WJ,  Strom SS,  Berndt SI,  Kittles RA,  Rybicki BA,  Isaacs WB,  Ingles SA,  Stanford JL,  Diver WR,  Witte JS,  Hsing AW,  Nemesure B,  Rebbeck TR,  Cooney KA,  Xu J,  Kibel AS,  Hu JJ,  John EM,  Gueye SM,  Watya S,  Signorello LB,  Hayes RB,  Wang Z,  Yeboah E,  Tettey Y,  Cai Q,  Kolb S,  Ostrander EA,  Zeigler-Johnson C,  Yamamura Y,  Neslund-Dudas C,  Haslag-Minoff J,  Wu W,  Thomas V,  Allen GO,  Murphy A,  Chang BL,  Zheng SL,  Leske MC,  Wu SY,  Ray AM,  Hennis AJ,  Thun MJ,  Carpten J,  Casey G,  Carter EN,  Duarte ER,  Xia LY,  Sheng X,  Wan P,  Pooler LC,  Cheng I,  Monroe KR,  Schumacher F,  Le Marchand L,  Kolonel LN,  Chanock SJ,  Van Den Berg D,  Stram DO,  Henderson BE
Nat Genet 2011 Jun;43(6):570-3
PubMed ID: 21602798
PMC ID: PMC3102788
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Fine mapping the KLK3 locus on chromosome 19q13.33 associated with prostate cancer susceptibility and PSA levels.

Parikh H,  Wang Z,  Pettigrew KA,  Jia J,  Daugherty S,  Yeager M,  Jacobs KB,  Hutchinson A,  Burdett L,  Cullen M,  Qi L,  Boland J,  Collins I,  Albert TJ,  Vatten LJ,  Hveem K,  Njølstad I,  Cancel-Tassin G,  Cussenot O,  Valeri A,  Virtamo J,  Thun MJ,  Feigelson HS,  Diver WR,  Chatterjee N,  Thomas G,  Albanes D,  Chanock SJ,  Hunter DJ,  Hoover R,  Hayes RB,  Berndt SI,  Sampson J,  Amundadottir L
Hum Genet 2011 Jun;129(6):675-85
PubMed ID: 21318478
PMC ID: PMC3092924
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Scar carcinoma of the lung: a historical perspective.

Bobba RK,  Holly JS,  Loy T,  Perry MC
Clin Lung Cancer 2011 May;12(3):148-54
PubMed ID: 21663856
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Non-steroidal anti-inflammatory drug and aspirin use and the risk of head and neck cancer: a systematic review.

Wilson JC,  Anderson LA,  Murray LJ,  Hughes CM
Cancer Causes Control 2011 May;22(5):803-10
PubMed ID: 21409528
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Nonsteroidal antiinflammatory drugs and bladder cancer: a pooled analysis.

Daugherty SE,  Pfeiffer RM,  Sigurdson AJ,  Hayes RB,  Leitzmann M,  Schatzkin A,  Hollenbeck AR,  Silverman DT
Am J Epidemiol 2011 Apr 1;173(7):721-30
PubMed ID: 21367875
PMC ID: PMC3105281
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Genome-wide meta-analysis identifies regions on 7p21 (AHR) and 15q24 (CYP1A2) as determinants of habitual caffeine consumption.

Cornelis MC,  Monda KL,  Yu K,  Paynter N,  Azzato EM,  Bennett SN,  Berndt SI,  Boerwinkle E,  Chanock S,  Chatterjee N,  Couper D,  Curhan G,  Heiss G,  Hu FB,  Hunter DJ,  Jacobs K,  Jensen MK,  Kraft P,  Landi MT,  Nettleton JA,  Purdue MP,  Rajaraman P,  Rimm EB,  Rose LM,  Rothman N,  Silverman D,  Stolzenberg-Solomon R,  Subar A,  Yeager M,  Chasman DI,  van Dam RM,  Caporaso NE
PLoS Genet 2011 Apr;7(4):e1002033
PubMed ID: 21490707
PMC ID: PMC3071630
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Hormone-related risk factors and postmenopausal breast cancer among nulliparous versus parous women: An aggregated study.

Schonfeld SJ,  Pfeiffer RM,  Lacey JV Jr,  Berrington de González A,  Doody MM,  Greenlee RT,  Park Y,  Schairer C,  Schatzkin A,  Sigurdson AJ,  Hartge P,  Visvanathan K
Am J Epidemiol 2011 Mar 1;173(5):509-17
PubMed ID: 21266505
PMC ID: PMC3105439
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Ovarian cancer biomarker performance in prostate, lung, colorectal, and ovarian cancer screening trial specimens.

Cramer DW,  Bast RC Jr,  Berg CD,  Diamandis EP,  Godwin AK,  Hartge P,  Lokshin AE,  Lu KH,  McIntosh MW,  Mor G,  Patriotis C,  Pinsky PF,  Thornquist MD,  Scholler N,  Skates SJ,  Sluss PM,  Srivastava S,  Ward DC,  Zhang Z,  Zhu CS,  Urban N
Cancer Prev Res (Phila) 2011 Mar;4(3):365-74
PubMed ID: 21372036
PMC ID: PMC3085251
Groups or Programs: Early DetectionCancer BiomarkersPLCO Cancer Screening Trial

A prospective evaluation of C-reactive protein levels and colorectal adenoma development.

Gunter MJ,  Cross AJ,  Huang WY,  Stanczyk FZ,  Purdue M,  Xue X,  Schoen R,  Limburg PJ,  Schatzkin A,  Sinha R,  Hayes RB
Cancer Epidemiol Biomarkers Prev 2011 Mar;20(3):537-44
PubMed ID: 21212059
PMC ID: PMC3051036
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Obesity and thyroid cancer risk among U.S. men and women: a pooled analysis of five prospective studies.

Kitahara CM,  Platz EA,  Freeman LE,  Hsing AW,  Linet MS,  Park Y,  Schairer C,  Schatzkin A,  Shikany JM,  Berrington de González A
Cancer Epidemiol Biomarkers Prev 2011 Mar;20(3):464-72
PubMed ID: 21266520
PMC ID: PMC3079276
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Pathologic findings following false-positive screening tests for ovarian cancer in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial.

Nyante SJ,  Black A,  Kreimer AR,  Duggan MA,  Carreon JD,  Kessel B,  Buys SS,  Ragard LR,  Johnson KA,  Dunn BK,  Lamerato L,  Commins JM,  Berg CD,  Sherman ME
Gynecol Oncol 2011 Mar;120(3):474-9
PubMed ID: 21144559
PMC ID: PMC3040283
Groups or Programs: Early DetectionPLCO Cancer Screening TrialChemopreventive Agent Development

A framework for evaluating biomarkers for early detection: validation of biomarker panels for ovarian cancer.

Zhu CS,  Pinsky PF,  Cramer DW,  Ransohoff DF,  Hartge P,  Pfeiffer RM,  Urban N,  Mor G,  Bast RC Jr,  Moore LE,  Lokshin AE,  McIntosh MW,  Skates SJ,  Vitonis A,  Zhang Z,  Ward DC,  Symanowski JT,  Lomakin A,  Fung ET,  Sluss PM,  Scholler N,  Lu KH,  Marrangoni AM,  Patriotis C,  Srivastava S,  Buys SS,  Berg CD,  PLCO Project Team
Cancer Prev Res (Phila) 2011 Mar;4(3):375-83
PubMed ID: 21372037
PMC ID: PMC3057372
Groups or Programs: Early DetectionCancer BiomarkersBiometryPLCO Cancer Screening Trial

Characterizing associations and SNP-environment interactions for GWAS-identified prostate cancer risk markers--results from BPC3.

Lindstrom S,  Schumacher F,  Siddiq A,  Travis RC,  Campa D,  Berndt SI,  Diver WR,  Severi G,  Allen N,  Andriole G,  Bueno-de-Mesquita B,  Chanock SJ,  Crawford D,  Gaziano JM,  Giles GG,  Giovannucci E,  Guo C,  Haiman CA,  Hayes RB,  Halkjaer J,  Hunter DJ,  Johansson M,  Kaaks R,  Kolonel LN,  Navarro C,  Riboli E,  Sacerdote C,  Stampfer M,  Stram DO,  Thun MJ,  Trichopoulos D,  Virtamo J,  Weinstein SJ,  Yeager M,  Henderson B,  Ma J,  Le Marchand L,  Albanes D,  Kraft P
PLoS One 2011 Feb 24;6(2):e17142
PubMed ID: 21390317
PMC ID: PMC3044744
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Comorbidity and mortality results from a randomized prostate cancer screening trial.

Crawford ED,  Grubb R 3rd,  Black A,  Andriole GL Jr,  Chen MH,  Izmirlian G,  Berg CD,  D'Amico AV
J Clin Oncol 2011 Feb 1;29(4):355-61
PubMed ID: 21041707
PMC ID: PMC3058283
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Serum C-reactive protein and risk of pancreatic cancer in two nested, case-control studies.

Douglas JB,  Silverman DT,  Weinstein SJ,  Graubard BI,  Pollak MN,  Tao Y,  Virtamo J,  Albanes D,  Stolzenberg-Solomon RZ
Cancer Epidemiol Biomarkers Prev 2011 Feb;20(2):359-69
PubMed ID: 21173171
PMC ID: PMC3495286
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

No effect of meat, meat cooking preferences, meat mutagens or heme iron on lung cancer risk in the prostate, lung, colorectal and ovarian cancer screening trial.

Tasevska N,  Cross AJ,  Dodd KW,  Ziegler RG,  Caporaso NE,  Sinha R
Int J Cancer 2011 Jan 15;128(2):402-11
PubMed ID: 20232386
PMC ID: PMC2970721
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Telomere length and variation in telomere biology genes in individuals with osteosarcoma.

Mirabello L,  Richards EG,  Duong LM,  Yu K,  Wang Z,  Cawthon R,  Berndt SI,  Burdett L,  Chowdhury S,  Teshome K,  Douglass C,  Savage SA,  National Osteosarcoma Etiology Study Group
Int J Mol Epidemiol Genet 2011 Jan 1;2(1):19-29
PubMed ID: 21537398
PMC ID: PMC3077235
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Targeted prostate cancer screening in men with mutations in BRCA1 and BRCA2 detects aggressive prostate cancer: preliminary analysis of the results of the IMPACT study.

Mitra AV,  Bancroft EK,  Barbachano Y,  Page EC,  Foster CS,  Jameson C,  Mitchell G,  Lindeman GJ,  Stapleton A,  Suthers G,  Evans DG,  Cruger D,  Blanco I,  Mercer C,  Kirk J,  Maehle L,  Hodgson S,  Walker L,  Izatt L,  Douglas F,  Tucker K,  Dorkins H,  Clowes V,  Male A,  Donaldson A,  Brewer C,  Doherty R,  Bulman B,  Osther PJ,  Salinas M,  Eccles D,  Axcrona K,  Jobson I,  Newcombe B,  Cybulski C,  Rubinstein WS,  Buys S,  Townshend S,  Friedman E,  Domchek S,  Ramon Y Cajal T,  Spigelman A,  Teo SH,  Nicolai N,  Aaronson N,  Ardern-Jones A,  Bangma C,  Dearnaley D,  Eyfjord J,  Falconer A,  Grönberg H,  Hamdy F,  Johannsson O,  Khoo V,  Kote-Jarai Z,  Lilja H,  Lubinski J,  Melia J,  Moynihan C,  Peock S,  Rennert G,  Schröder F,  Sibley P,  Suri M,  Wilson P,  Bignon YJ,  Strom S,  Tischkowitz M,  Liljegren A,  Ilencikova D,  Abele A,  Kyriacou K,  van Asperen C,  Kiemeney L,  IMPACT Study Collaborators,  Easton DF,  Eeles RA
BJU Int 2011 Jan;107(1):28-39
PubMed ID: 20840664
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Genome-wide association study of renal cell carcinoma identifies two susceptibility loci on 2p21 and 11q13.3.

Purdue MP,  Johansson M,  Zelenika D,  Toro JR,  Scelo G,  Moore LE,  Prokhortchouk E,  Wu X,  Kiemeney LA,  Gaborieau V,  Jacobs KB,  Chow WH,  Zaridze D,  Matveev V,  Lubinski J,  Trubicka J,  Szeszenia-Dabrowska N,  Lissowska J,  Rudnai P,  Fabianova E,  Bucur A,  Bencko V,  Foretova L,  Janout V,  Boffetta P,  Colt JS,  Davis FG,  Schwartz KL,  Banks RE,  Selby PJ,  Harnden P,  Berg CD,  Hsing AW,  Grubb RL 3rd,  Boeing H,  Vineis P,  Clavel-Chapelon F,  Palli D,  Tumino R,  Krogh V,  Panico S,  Duell EJ,  Quirós JR,  Sanchez MJ,  Navarro C,  Ardanaz E,  Dorronsoro M,  Khaw KT,  Allen NE,  Bueno-de-Mesquita HB,  Peeters PH,  Trichopoulos D,  Linseisen J,  Ljungberg B,  Overvad K,  Tjønneland A,  Romieu I,  Riboli E,  Mukeria A,  Shangina O,  Stevens VL,  Thun MJ,  Diver WR,  Gapstur SM,  Pharoah PD,  Easton DF,  Albanes D,  Weinstein SJ,  Virtamo J,  Vatten L,  Hveem K,  Njølstad I,  Tell GS,  Stoltenberg C,  Kumar R,  Koppova K,  Cussenot O,  Benhamou S,  Oosterwijk E,  Vermeulen SH,  Aben KK,  van der Marel SL,  Ye Y,  Wood CG,  Pu X,  Mazur AM,  Boulygina ES,  Chekanov NN,  Foglio M,  Lechner D,  Gut I,  Heath S,  Blanche H,  Hutchinson A,  Thomas G,  Wang Z,  Yeager M,  Fraumeni JF Jr,  Skryabin KG,  McKay JD,  Rothman N,  Chanock SJ,  Lathrop M,  Brennan P
Nat Genet 2011 Jan;43(1):60-5
PubMed ID: 21131975
PMC ID: PMC3049257
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Prospective analysis of DNA damage and repair markers of lung cancer risk from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Sigurdson AJ,  Jones IM,  Wei Q,  Wu X,  Spitz MR,  Stram DA,  Gross MD,  Huang WY,  Wang LE,  Gu J,  Thomas CB,  Reding DJ,  Hayes RB,  Caporaso NE
Carcinogenesis 2011 Jan;32(1):69-73
PubMed ID: 20929901
PMC ID: PMC3010173
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Building multi-marker algorithms for disease prediction-the role of correlations among markers.

Pinsky PF,  Zhu CS
Biomark Insights 2011;6:83-93
PubMed ID: 21918599
PMC ID: PMC3169344
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Genetic variation on 9p22 is associated with abnormal ovarian ultrasound results in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Wentzensen N,  Black A,  Jacobs K,  Yang HP,  Berg CD,  Caporaso N,  Peters U,  Ragard L,  Buys SS,  Chanock S,  Hartge P
PLoS One 2011;6(7):e21731
PubMed ID: 21750727
PMC ID: PMC3131287
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Non-steroidal anti-inflammatory drug use and colorectal polyps in the Prostate, Lung, Colorectal, And Ovarian Cancer Screening Trial.

Johnson CC,  Hayes RB,  Schoen RE,  Gunter MJ,  Huang WY,  PLCO Trial Team
Am J Gastroenterol 2010 Dec;105(12):2646-55
PubMed ID: 20808298
PMC ID: PMC5557093
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Characterization of 9p24 risk locus and colorectal adenoma and cancer: gene-environment interaction and meta-analysis.

Kocarnik JD,  Hutter CM,  Slattery ML,  Berndt SI,  Hsu L,  Duggan DJ,  Muehling J,  Caan BJ,  Beresford SA,  Rajkovic A,  Sarto GE,  Marshall JR,  Hammad N,  Wallace RB,  Makar KW,  Prentice RL,  Potter JD,  Hayes RB,  Peters U
Cancer Epidemiol Biomarkers Prev 2010 Dec;19(12):3131-9
PubMed ID: 20978172
PMC ID: PMC3005543
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Variant ABO blood group alleles, secretor status, and risk of pancreatic cancer: results from the pancreatic cancer cohort consortium.

Wolpin BM,  Kraft P,  Xu M,  Steplowski E,  Olsson ML,  Arslan AA,  Bueno-de-Mesquita HB,  Gross M,  Helzlsouer K,  Jacobs EJ,  LaCroix A,  Petersen G,  Stolzenberg-Solomon RZ,  Zheng W,  Albanes D,  Allen NE,  Amundadottir L,  Austin MA,  Boutron-Ruault MC,  Buring JE,  Canzian F,  Chanock SJ,  Gaziano JM,  Giovannucci EL,  Hallmans G,  Hankinson SE,  Hoover RN,  Hunter DJ,  Hutchinson A,  Jacobs KB,  Kooperberg C,  Mendelsohn JB,  Michaud DS,  Overvad K,  Patel AV,  Sanchéz MJ,  Sansbury L,  Shu XO,  Slimani N,  Tobias GS,  Trichopoulos D,  Vineis P,  Visvanathan K,  Virtamo J,  Wactawski-Wende J,  Watters J,  Yu K,  Zeleniuch-Jacquotte A,  Hartge P,  Fuchs CS
Cancer Epidemiol Biomarkers Prev 2010 Dec;19(12):3140-9
PubMed ID: 20971884
PMC ID: PMC3005538
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index.

Speliotes EK,  Willer CJ,  Berndt SI,  Monda KL,  Thorleifsson G,  Jackson AU,  Lango Allen H,  Lindgren CM,  Luan J,  Mägi R,  Randall JC,  Vedantam S,  Winkler TW,  Qi L,  Workalemahu T,  Heid IM,  Steinthorsdottir V,  Stringham HM,  Weedon MN,  Wheeler E,  Wood AR,  Ferreira T,  Weyant RJ,  Segrè AV,  Estrada K,  Liang L,  Nemesh J,  Park JH,  Gustafsson S,  Kilpeläinen TO,  Yang J,  Bouatia-Naji N,  Esko T,  Feitosa MF,  Kutalik Z,  Mangino M,  Raychaudhuri S,  Scherag A,  Smith AV,  Welch R,  Zhao JH,  Aben KK,  Absher DM,  Amin N,  Dixon AL,  Fisher E,  Glazer NL,  Goddard ME,  Heard-Costa NL,  Hoesel V,  Hottenga JJ,  Johansson A,  Johnson T,  Ketkar S,  Lamina C,  Li S,  Moffatt MF,  Myers RH,  Narisu N,  Perry JR,  Peters MJ,  Preuss M,  Ripatti S,  Rivadeneira F,  Sandholt C,  Scott LJ,  Timpson NJ,  Tyrer JP,  van Wingerden S,  Watanabe RM,  White CC,  Wiklund F,  Barlassina C,  Chasman DI,  Cooper MN,  Jansson JO,  Lawrence RW,  Pellikka N,  Prokopenko I,  Shi J,  Thiering E,  Alavere H,  Alibrandi MT,  Almgren P,  Arnold AM,  Aspelund T,  Atwood LD,  Balkau B,  Balmforth AJ,  Bennett AJ,  Ben-Shlomo Y,  Bergman RN,  Bergmann S,  Biebermann H,  Blakemore AI,  Boes T,  Bonnycastle LL,  Bornstein SR,  Brown MJ,  Buchanan TA,  Busonero F,  Campbell H,  Cappuccio FP,  Cavalcanti-Proença C,  Chen YD,  Chen CM,  Chines PS,  Clarke R,  Coin L,  Connell J,  Day IN,  den Heijer M,  Duan J,  Ebrahim S,  Elliott P,  Elosua R,  Eiriksdottir G,  Erdos MR,  Eriksson JG,  Facheris MF,  Felix SB,  Fischer-Posovszky P,  Folsom AR,  Friedrich N,  Freimer NB,  Fu M,  Gaget S,  Gejman PV,  Geus EJ,  Gieger C,  Gjesing AP,  Goel A,  Goyette P,  Grallert H,  Grässler J,  Greenawalt DM,  Groves CJ,  Gudnason V,  Guiducci C,  Hartikainen AL,  Hassanali N,  Hall AS,  Havulinna AS,  Hayward C,  Heath AC,  Hengstenberg C,  Hicks AA,  Hinney A,  Hofman A,  Homuth G,  Hui J,  Igl W,  Iribarren C,  Isomaa B,  Jacobs KB,  Jarick I,  Jewell E,  John U,  Jørgensen T,  Jousilahti P,  Jula A,  Kaakinen M,  Kajantie E,  Kaplan LM,  Kathiresan S,  Kettunen J,  Kinnunen L,  Knowles JW,  Kolcic I,  König IR,  Koskinen S,  Kovacs P,  Kuusisto J,  Kraft P,  Kvaløy K,  Laitinen J,  Lantieri O,  Lanzani C,  Launer LJ,  Lecoeur C,  Lehtimäki T,  Lettre G,  Liu J,  Lokki ML,  Lorentzon M,  Luben RN,  Ludwig B,  MAGIC,  Manunta P,  Marek D,  Marre M,  Martin NG,  McArdle WL,  McCarthy A,  McKnight B,  Meitinger T,  Melander O,  Meyre D,  Midthjell K,  Montgomery GW,  Morken MA,  Morris AP,  Mulic R,  Ngwa JS,  Nelis M,  Neville MJ,  Nyholt DR,  O'Donnell CJ,  O'Rahilly S,  Ong KK,  Oostra B,  Paré G,  Parker AN,  Perola M,  Pichler I,  Pietiläinen KH,  Platou CG,  Polasek O,  Pouta A,  Rafelt S,  Raitakari O,  Rayner NW,  Ridderstråle M,  Rief W,  Ruokonen A,  Robertson NR,  Rzehak P,  Salomaa V,  Sanders AR,  Sandhu MS,  Sanna S,  Saramies J,  Savolainen MJ,  Scherag S,  Schipf S,  Schreiber S,  Schunkert H,  Silander K,  Sinisalo J,  Siscovick DS,  Smit JH,  Soranzo N,  Sovio U,  Stephens J,  Surakka I,  Swift AJ,  Tammesoo ML,  Tardif JC,  Teder-Laving M,  Teslovich TM,  Thompson JR,  Thomson B,  Tönjes A,  Tuomi T,  van Meurs JB,  van Ommen GJ,  Vatin V,  Viikari J,  Visvikis-Siest S,  Vitart V,  Vogel CI,  Voight BF,  Waite LL,  Wallaschofski H,  Walters GB,  Widen E,  Wiegand S,  Wild SH,  Willemsen G,  Witte DR,  Witteman JC,  Xu J,  Zhang Q,  Zgaga L,  Ziegler A,  Zitting P,  Beilby JP,  Farooqi IS,  Hebebrand J,  Huikuri HV,  James AL,  Kähönen M,  Levinson DF,  Macciardi F,  Nieminen MS,  Ohlsson C,  Palmer LJ,  Ridker PM,  Stumvoll M,  Beckmann JS,  Boeing H,  Boerwinkle E,  Boomsma DI,  Caulfield MJ,  Chanock SJ,  Collins FS,  Cupples LA,  Smith GD,  Erdmann J,  Froguel P,  Grönberg H,  Gyllensten U,  Hall P,  Hansen T,  Harris TB,  Hattersley AT,  Hayes RB,  Heinrich J,  Hu FB,  Hveem K,  Illig T,  Jarvelin MR,  Kaprio J,  Karpe F,  Khaw KT,  Kiemeney LA,  Krude H,  Laakso M,  Lawlor DA,  Metspalu A,  Munroe PB,  Ouwehand WH,  Pedersen O,  Penninx BW,  Peters A,  Pramstaller PP,  Quertermous T,  Reinehr T,  Rissanen A,  Rudan I,  Samani NJ,  Schwarz PE,  Shuldiner AR,  Spector TD,  Tuomilehto J,  Uda M,  Uitterlinden A,  Valle TT,  Wabitsch M,  Waeber G,  Wareham NJ,  Watkins H,  Procardis Consortium,  Wilson JF,  Wright AF,  Zillikens MC,  Chatterjee N,  McCarroll SA,  Purcell S,  Schadt EE,  Visscher PM,  Assimes TL,  Borecki IB,  Deloukas P,  Fox CS,  Groop LC,  Haritunians T,  Hunter DJ,  Kaplan RC,  Mohlke KL,  O'Connell JR,  Peltonen L,  Schlessinger D,  Strachan DP,  van Duijn CM,  Wichmann HE,  Frayling TM,  Thorsteinsdottir U,  Abecasis GR,  Barroso I,  Boehnke M,  Stefansson K,  North KE,  McCarthy MI,  Hirschhorn JN,  Ingelsson E,  Loos RJ
Nat Genet 2010 Nov;42(11):937-48
PubMed ID: 20935630
PMC ID: PMC3014648
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Comprehensive analysis of common genetic variation in 61 genes related to steroid hormone and insulin-like growth factor-I metabolism and breast cancer risk in the NCI breast and prostate cancer cohort consortium.

Canzian F,  Cox DG,  Setiawan VW,  Stram DO,  Ziegler RG,  Dossus L,  Beckmann L,  Blanché H,  Barricarte A,  Berg CD,  Bingham S,  Buring J,  Buys SS,  Calle EE,  Chanock SJ,  Clavel-Chapelon F,  DeLancey JO,  Diver WR,  Dorronsoro M,  Haiman CA,  Hallmans G,  Hankinson SE,  Hunter DJ,  Hüsing A,  Isaacs C,  Khaw KT,  Kolonel LN,  Kraft P,  Le Marchand L,  Lund E,  Overvad K,  Panico S,  Peeters PH,  Pollak M,  Thun MJ,  Tjønneland A,  Trichopoulos D,  Tumino R,  Yeager M,  Hoover RN,  Riboli E,  Thomas G,  Henderson BE,  Kaaks R,  Feigelson HS
Hum Mol Genet 2010 Oct 1;19(19):3873-84
PubMed ID: 20634197
PMC ID: PMC2935856
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

The potential for enhancing the power of genetic association studies in African Americans through the reuse of existing genotype data.

Chen GK,  Millikan RC,  John EM,  Ambrosone CB,  Bernstein L,  Zheng W,  Hu JJ,  Chanock SJ,  Ziegler RG,  Bandera EV,  Henderson BE,  Haiman CA,  Stram DO
PLoS Genet 2010 Sep 2;6(9):e1001096
PubMed ID: 20824062
PMC ID: PMC2932740
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Serum IGF-I, IGF-II, IGFBP-3, and IGF-I/IGFBP-3 molar ratio and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.

Douglas JB,  Silverman DT,  Pollak MN,  Tao Y,  Soliman AS,  Stolzenberg-Solomon RZ
Cancer Epidemiol Biomarkers Prev 2010 Sep;19(9):2298-306
PubMed ID: 20699371
PMC ID: PMC2936681
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Prostate cancer screening: current status and future perspectives.

Strope SA,  Andriole GL
Nat Rev Urol 2010 Sep;7(9):487-93
PubMed ID: 20818326
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Polymorphisms in the adenomatous polyposis coli (APC) gene and advanced colorectal adenoma risk.

Wong HL,  Peters U,  Hayes RB,  Huang WY,  Schatzkin A,  Bresalier RS,  Velie EM,  Brody LC
Eur J Cancer 2010 Sep;46(13):2457-66
PubMed ID: 20510605
PMC ID: PMC2924917
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Interaction of CYP1B1, cigarette-smoke carcinogen metabolism, and lung cancer risk.

Church TR,  Haznadar M,  Geisser MS,  Anderson KE,  Caporaso NE,  Le C,  Abdullah SB,  Hecht SS,  Oken MM,  Van Ness B
Int J Mol Epidemiol Genet 2010 Aug 5;1(4):295-309
PubMed ID: 21532841
PMC ID: PMC3076775
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Alcohol intake and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium (PanScan).

Michaud DS,  Vrieling A,  Jiao L,  Mendelsohn JB,  Steplowski E,  Lynch SM,  Wactawski-Wende J,  Arslan AA,  Bas Bueno-de-Mesquita H,  Fuchs CS,  Gross M,  Helzlsouer K,  Jacobs EJ,  Lacroix A,  Petersen G,  Zheng W,  Allen N,  Ammundadottir L,  Bergmann MM,  Boffetta P,  Buring JE,  Canzian F,  Chanock SJ,  Clavel-Chapelon F,  Clipp S,  Freiberg MS,  Michael Gaziano J,  Giovannucci EL,  Hankinson S,  Hartge P,  Hoover RN,  Allan Hubbell F,  Hunter DJ,  Hutchinson A,  Jacobs K,  Kooperberg C,  Kraft P,  Manjer J,  Navarro C,  Peeters PH,  Shu XO,  Stevens V,  Thomas G,  Tjønneland A,  Tobias GS,  Trichopoulos D,  Tumino R,  Vineis P,  Virtamo J,  Wallace R,  Wolpin BM,  Yu K,  Zeleniuch-Jacquotte A,  Stolzenberg-Solomon RZ
Cancer Causes Control 2010 Aug;21(8):1213-25
PubMed ID: 20373013
PMC ID: PMC3098295
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Genetic variation at chromosome 8q24 in osteosarcoma cases and controls.

Mirabello L,  Berndt SI,  Seratti GF,  Burdett L,  Yeager M,  Chowdhury S,  Teshome K,  Uzoka A,  Douglass C,  Hayes RB,  Hoover RN,  Savage SA,  National Osteosarcoma Etiology Study Group
Carcinogenesis 2010 Aug;31(8):1400-4
PubMed ID: 20530236
PMC ID: PMC2915635
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Assessing contamination and compliance in the prostate component of the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.

Pinsky PF,  Blacka A,  Kramer BS,  Miller A,  Prorok PC,  Berg C
Clin Trials 2010 Aug;7(4):303-11
PubMed ID: 20571134
PMC ID: not available
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Circulating 25-hydroxyvitamin D and risk of esophageal and gastric cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

Abnet CC,  Chen Y,  Chow WH,  Gao YT,  Helzlsouer KJ,  Le Marchand L,  McCullough ML,  Shikany JM,  Virtamo J,  Weinstein SJ,  Xiang YB,  Yu K,  Zheng W,  Albanes D,  Arslan AA,  Campbell DS,  Campbell PT,  Hayes RB,  Horst RL,  Kolonel LN,  Nomura AM,  Purdue MP,  Snyder K,  Shu XO
Am J Epidemiol 2010 Jul 1;172(1):94-106
PubMed ID: 20562192
PMC ID: PMC2892544
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Genome-wide association study of circulating vitamin D levels.

Ahn J,  Yu K,  Stolzenberg-Solomon R,  Simon KC,  McCullough ML,  Gallicchio L,  Jacobs EJ,  Ascherio A,  Helzlsouer K,  Jacobs KB,  Li Q,  Weinstein SJ,  Purdue M,  Virtamo J,  Horst R,  Wheeler W,  Chanock S,  Hunter DJ,  Hayes RB,  Kraft P,  Albanes D
Hum Mol Genet 2010 Jul 1;19(13):2739-45
PubMed ID: 20418485
PMC ID: PMC2883344
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Circulating 25-hydroxyvitamin D and the risk of rarer cancers: Design and methods of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

Gallicchio L,  Helzlsouer KJ,  Chow WH,  Freedman DM,  Hankinson SE,  Hartge P,  Hartmuller V,  Harvey C,  Hayes RB,  Horst RL,  Koenig KL,  Kolonel LN,  Laden F,  McCullough ML,  Parisi D,  Purdue MP,  Shu XO,  Snyder K,  Stolzenberg-Solomon RZ,  Tworoger SS,  Varanasi A,  Virtamo J,  Wilkens LR,  Xiang YB,  Yu K,  Zeleniuch-Jacquotte A,  Zheng W,  Abnet CC,  Albanes D,  Bertrand K,  Weinstein SJ
Am J Epidemiol 2010 Jul 1;172(1):10-20
PubMed ID: 20562188
PMC ID: PMC2892539
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Circulating 25-hydroxyvitamin D and risk of kidney cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

Gallicchio L,  Moore LE,  Stevens VL,  Ahn J,  Albanes D,  Hartmuller V,  Setiawan VW,  Helzlsouer KJ,  Yang G,  Xiang YB,  Shu XO,  Snyder K,  Weinstein SJ,  Yu K,  Zeleniuch-Jacquotte A,  Zheng W,  Cai Q,  Campbell DS,  Chen Y,  Chow WH,  Horst RL,  Kolonel LN,  McCullough ML,  Purdue MP,  Koenig KL
Am J Epidemiol 2010 Jul 1;172(1):47-57
PubMed ID: 20562187
PMC ID: PMC2892538
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Overview of the Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

Helzlsouer KJ,  VDPP Steering Committee
Am J Epidemiol 2010 Jul 1;172(1):4-9
PubMed ID: 20562193
PMC ID: PMC2892542
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Correlates of circulating 25-hydroxyvitamin D: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

McCullough ML,  Weinstein SJ,  Freedman DM,  Helzlsouer K,  Flanders WD,  Koenig K,  Kolonel L,  Laden F,  Le Marchand L,  Purdue M,  Snyder K,  Stevens VL,  Stolzenberg-Solomon R,  Virtamo J,  Yang G,  Yu K,  Zheng W,  Albanes D,  Ashby J,  Bertrand K,  Cai H,  Chen Y,  Gallicchio L,  Giovannucci E,  Jacobs EJ,  Hankinson SE,  Hartge P,  Hartmuller V,  Harvey C,  Hayes RB,  Horst RL,  Shu XO
Am J Epidemiol 2010 Jul 1;172(1):21-35
PubMed ID: 20562191
PMC ID: PMC2892536
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Circulating 25-hydroxyvitamin D and risk of non-hodgkin lymphoma: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

Purdue MP,  Freedman DM,  Gapstur SM,  Helzlsouer KJ,  Laden F,  Lim U,  Maskarinec G,  Rothman N,  Shu XO,  Stevens VL,  Zeleniuch-Jacquotte A,  Albanes D,  Bertrand K,  Weinstein SJ,  Yu K,  Irish L,  Horst RL,  Hoffman-Bolton J,  Giovannucci EL,  Kolonel LN,  Snyder K,  Willett W,  Arslan AA,  Hayes RB,  Zheng W,  Xiang YB,  Hartge P
Am J Epidemiol 2010 Jul 1;172(1):58-69
PubMed ID: 20562184
PMC ID: PMC2892540
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Circulating 25-hydroxyvitamin D and risk of pancreatic cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

Stolzenberg-Solomon RZ,  Jacobs EJ,  Arslan AA,  Qi D,  Patel AV,  Helzlsouer KJ,  Weinstein SJ,  McCullough ML,  Purdue MP,  Shu XO,  Snyder K,  Virtamo J,  Wilkins LR,  Yu K,  Zeleniuch-Jacquotte A,  Zheng W,  Albanes D,  Cai Q,  Harvey C,  Hayes R,  Clipp S,  Horst RL,  Irish L,  Koenig K,  Le Marchand L,  Kolonel LN
Am J Epidemiol 2010 Jul 1;172(1):81-93
PubMed ID: 20562185
PMC ID: PMC2892543
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Circulating 25-hydroxyvitamin D and risk of endometrial cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

Zeleniuch-Jacquotte A,  Gallicchio L,  Hartmuller V,  Helzlsouer KJ,  McCullough ML,  Setiawan VW,  Shu XO,  Weinstein SJ,  Weiss JM,  Arslan AA,  De Vivo I,  Gao YT,  Hayes RB,  Henderson BE,  Horst RL,  Koenig KL,  Patel AV,  Purdue MP,  Snyder K,  Steplowski E,  Yu K,  Zheng W,  Hankinson SE
Am J Epidemiol 2010 Jul 1;172(1):36-46
PubMed ID: 20562189
PMC ID: PMC2892537
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Circulating 25-hydroxyvitamin D and risk of epithelial ovarian cancer: Cohort Consortium Vitamin D Pooling Project of Rarer Cancers.

Zheng W,  Danforth KN,  Tworoger SS,  Goodman MT,  Arslan AA,  Patel AV,  McCullough ML,  Weinstein SJ,  Kolonel LN,  Purdue MP,  Shu XO,  Snyder K,  Steplowski E,  Visvanathan K,  Yu K,  Zeleniuch-Jacquotte A,  Gao YT,  Hankinson SE,  Harvey C,  Hayes RB,  Henderson BE,  Horst RL,  Helzlsouer KJ
Am J Epidemiol 2010 Jul 1;172(1):70-80
PubMed ID: 20562186
PMC ID: PMC2892541
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Low vitamin D status is associated with physical inactivity, obesity and low vitamin D intake in a large US sample of healthy middle-aged men and women.

Brock K,  Huang WY,  Fraser DR,  Ke L,  Tseng M,  Stolzenberg-Solomon R,  Peters U,  Ahn J,  Purdue M,  Mason RS,  McCarty C,  Ziegler RG,  Graubard B
J Steroid Biochem Mol Biol 2010 Jul;121(1-2):462-6
PubMed ID: 20399270
PMC ID: PMC2906665
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Association between genetic variants in the 8q24 cancer risk regions and circulating levels of androgens and sex hormone-binding globulin.

Chu LW,  Meyer TE,  Li Q,  Menashe I,  Yu K,  Rosenberg PS,  Huang WY,  Quraishi SM,  Kaaks R,  Weiss JM,  Hayes RB,  Chanock SJ,  Hsing AW
Cancer Epidemiol Biomarkers Prev 2010 Jul;19(7):1848-54
PubMed ID: 20551303
PMC ID: PMC2901401
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Using cases to strengthen inference on the association between single nucleotide polymorphisms and a secondary phenotype in genome-wide association studies.

Li H,  Gail MH,  Berndt S,  Chatterjee N
Genet Epidemiol 2010 Jul;34(5):427-33
PubMed ID: 20583284
PMC ID: PMC2918520
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

One year recurrence of aberrant crypt foci.

Pinsky PF,  Fleshman J,  Mutch M,  Rall C,  Charabaty A,  Seligson D,  Dry S,  Umar A,  Schoen RE
Cancer Prev Res (Phila) 2010 Jul;3(7):839-43
PubMed ID: 20570885
PMC ID: PMC2900400
Groups or Programs: Gastrointestinal and Other CancersEarly DetectionPLCO Cancer Screening Trial

Associations between anthropometry, cigarette smoking, alcohol consumption, and non-Hodgkin lymphoma in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Troy JD,  Hartge P,  Weissfeld JL,  Oken MM,  Colditz GA,  Mechanic LE,  Morton LM
Am J Epidemiol 2010 Jun 15;171(12):1270-81
PubMed ID: 20494998
PMC ID: PMC2915494
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

C-reactive protein and risk of lung cancer.

Chaturvedi AK,  Caporaso NE,  Katki HA,  Wong HL,  Chatterjee N,  Pine SR,  Chanock SJ,  Goedert JJ,  Engels EA
J Clin Oncol 2010 Jun 1;28(16):2719-26
PubMed ID: 20421535
PMC ID: PMC2881850
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Available carbohydrates, glycemic load, and pancreatic cancer: is there a link?

Meinhold CL,  Dodd KW,  Jiao L,  Flood A,  Shikany JM,  Genkinger JM,  Hayes RB,  Stolzenberg-Solomon RZ
Am J Epidemiol 2010 Jun 1;171(11):1174-82
PubMed ID: 20452999
PMC ID: PMC2915491
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Insulin-like growth factor 1 (IGF1), IGF binding protein 3 (IGFBP3), and breast cancer risk: pooled individual data analysis of 17 prospective studies.

Endogenous Hormones and Breast Cancer Collaborative Group,  Key TJ,  Appleby PN,  Reeves GK,  Roddam AW
Lancet Oncol 2010 Jun;11(6):530-42
PubMed ID: 20472501
PMC ID: PMC3113287
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Cancer screening trials: nuts and bolts.

Prorok PC,  Marcus PM
Semin Oncol 2010 Jun;37(3):216-23
PubMed ID: 20709206
PMC ID: PMC2923646
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Lung cancer screening in the randomized Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.

Hocking WG,  Hu P,  Oken MM,  Winslow SD,  Kvale PA,  Prorok PC,  Ragard LR,  Commins J,  Lynch DA,  Andriole GL,  Buys SS,  Fouad MN,  Fuhrman CR,  Isaacs C,  Yokochi LA,  Riley TL,  Pinsky PF,  Gohagan JK,  Berg CD,  PLCO Project Team
J Natl Cancer Inst 2010 May 19;102(10):722-31
PubMed ID: 20442215
PMC ID: PMC2873186
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Anthropometric measures, body mass index, and pancreatic cancer: a pooled analysis from the Pancreatic Cancer Cohort Consortium (PanScan).

Arslan AA,  Helzlsouer KJ,  Kooperberg C,  Shu XO,  Steplowski E,  Bueno-de-Mesquita HB,  Fuchs CS,  Gross MD,  Jacobs EJ,  Lacroix AZ,  Petersen GM,  Stolzenberg-Solomon RZ,  Zheng W,  Albanes D,  Amundadottir L,  Bamlet WR,  Barricarte A,  Bingham SA,  Boeing H,  Boutron-Ruault MC,  Buring JE,  Chanock SJ,  Clipp S,  Gaziano JM,  Giovannucci EL,  Hankinson SE,  Hartge P,  Hoover RN,  Hunter DJ,  Hutchinson A,  Jacobs KB,  Kraft P,  Lynch SM,  Manjer J,  Manson JE,  McTiernan A,  McWilliams RR,  Mendelsohn JB,  Michaud DS,  Palli D,  Rohan TE,  Slimani N,  Thomas G,  Tjønneland A,  Tobias GS,  Trichopoulos D,  Virtamo J,  Wolpin BM,  Yu K,  Zeleniuch-Jacquotte A,  Patel AV,  Pancreatic Cancer Cohort Consortium (PanScan)
Arch Intern Med 2010 May 10;170(9):791-802
PubMed ID: 20458087
PMC ID: PMC2920035
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Effect of changing breast cancer incidence rates on the calibration of the Gail model.

Schonfeld SJ,  Pee D,  Greenlee RT,  Hartge P,  Lacey JV Jr,  Park Y,  Schatzkin A,  Visvanathan K,  Pfeiffer RM
J Clin Oncol 2010 May 10;28(14):2411-7
PubMed ID: 20368565
PMC ID: PMC2881722
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Association of CASP8 D302H polymorphism with reduced risk of aggressive prostate carcinoma.

Lubahn J,  Berndt SI,  Jin CH,  Klim A,  Luly J,  Wu WS,  Isaacs S,  Wiley K,  Isaacs WB,  Suarez BK,  Hayes RB,  Kibel AS
Prostate 2010 May 1;70(6):646-53
PubMed ID: 20033885
PMC ID: PMC3072829
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

HNF1B and JAZF1 genes, diabetes, and prostate cancer risk.

Stevens VL,  Ahn J,  Sun J,  Jacobs EJ,  Moore SC,  Patel AV,  Berndt SI,  Albanes D,  Hayes RB
Prostate 2010 May 1;70(6):601-7
PubMed ID: 19998368
PMC ID: PMC3086139
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Race and colorectal cancer disparities: health-care utilization vs different cancer susceptibilities.

Laiyemo AO,  Doubeni C,  Pinsky PF,  Doria-Rose VP,  Bresalier R,  Lamerato LE,  Crawford ED,  Kvale P,  Fouad M,  Hickey T,  Riley T,  Weissfeld J,  Schoen RE,  Marcus PM,  Prorok PC,  Berg CD
J Natl Cancer Inst 2010 Apr 21;102(8):538-46
PubMed ID: 20357245
PMC ID: PMC2857802
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Cumulative incidence of false-positive test results in lung cancer screening: a randomized trial.

Croswell JM,  Baker SG,  Marcus PM,  Clapp JD,  Kramer BS
Ann Intern Med 2010 Apr 20;152(8):505-80
PubMed ID: 20404381
PMC ID: not available
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Prevalence, incidence, and natural history of simple ovarian cysts among women >55 years old in a large cancer screening trial.

Greenlee RT,  Kessel B,  Williams CR,  Riley TL,  Ragard LR,  Hartge P,  Buys SS,  Partridge EE,  Reding DJ
Am J Obstet Gynecol 2010 Apr;202(4):373.e1-9
PubMed ID: 20096820
PMC ID: PMC2847634
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Long-term variation in serum 25-hydroxyvitamin D concentration among participants in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Hofmann JN,  Yu K,  Horst RL,  Hayes RB,  Purdue MP
Cancer Epidemiol Biomarkers Prev 2010 Apr;19(4):927-31
PubMed ID: 20332255
PMC ID: PMC2857993
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Circulating insulin-like growth factor (IGF)-I and IGF binding protein (IGFBP)-3 levels and postmenopausal breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial (PLCO) cohort.

Schairer C,  McCarty CA,  Isaacs C,  Sue LY,  Pollak MN,  Berg CD,  Ziegler RG
Horm Cancer 2010 Apr;1(2):100-11
PubMed ID: 21761353
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

A note on the effect on power of score tests via dimension reduction by penalized regression under the null.

Martinez JG,  Carroll RJ,  Muller S,  Sampson JN,  Chatterjee N
Int J Biostat 2010 Mar 29;6(1):Article 12
PubMed ID: 20405045
PMC ID: PMC2854087
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Pooled analysis of phosphatidylinositol 3-kinase pathway variants and risk of prostate cancer.

Koutros S,  Schumacher FR,  Hayes RB,  Ma J,  Huang WY,  Albanes D,  Canzian F,  Chanock SJ,  Crawford ED,  Diver WR,  Feigelson HS,  Giovanucci E,  Haiman CA,  Henderson BE,  Hunter DJ,  Kaaks R,  Kolonel LN,  Kraft P,  Le Marchand L,  Riboli E,  Siddiq A,  Stampfer MJ,  Stram DO,  Thomas G,  Travis RC,  Thun MJ,  Yeager M,  Berndt SI
Cancer Res 2010 Mar 15;70(6):2389-96
PubMed ID: 20197460
PMC ID: PMC2840184
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

PTGS2 and IL6 genetic variation and risk of breast and prostate cancer: results from the Breast and Prostate Cancer Cohort Consortium (BPC3).

Dossus L,  Kaaks R,  Canzian F,  Albanes D,  Berndt SI,  Boeing H,  Buring J,  Chanock SJ,  Clavel-Chapelon F,  Feigelson HS,  Gaziano JM,  Giovannucci E,  Gonzalez C,  Haiman CA,  Hallmans G,  Hankinson SE,  Hayes RB,  Henderson BE,  Hoover RN,  Hunter DJ,  Khaw KT,  Kolonel LN,  Kraft P,  Ma J,  Le Marchand L,  Lund E,  Peeters PH,  Stampfer M,  Stram DO,  Thomas G,  Thun MJ,  Tjonneland A,  Trichopoulos D,  Tumino R,  Riboli E,  Virtamo J,  Weinstein SJ,  Yeager M,  Ziegler RG,  Cox DG
Carcinogenesis 2010 Mar;31(3):455-61
PubMed ID: 19965896
PMC ID: PMC2832545
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

A genome-wide association study identifies pancreatic cancer susceptibility loci on chromosomes 13q22.1, 1q32.1 and 5p15.33.

Petersen GM,  Amundadottir L,  Fuchs CS,  Kraft P,  Stolzenberg-Solomon RZ,  Jacobs KB,  Arslan AA,  Bueno-de-Mesquita HB,  Gallinger S,  Gross M,  Helzlsouer K,  Holly EA,  Jacobs EJ,  Klein AP,  LaCroix A,  Li D,  Mandelson MT,  Olson SH,  Risch HA,  Zheng W,  Albanes D,  Bamlet WR,  Berg CD,  Boutron-Ruault MC,  Buring JE,  Bracci PM,  Canzian F,  Clipp S,  Cotterchio M,  de Andrade M,  Duell EJ,  Gaziano JM,  Giovannucci EL,  Goggins M,  Hallmans G,  Hankinson SE,  Hassan M,  Howard B,  Hunter DJ,  Hutchinson A,  Jenab M,  Kaaks R,  Kooperberg C,  Krogh V,  Kurtz RC,  Lynch SM,  McWilliams RR,  Mendelsohn JB,  Michaud DS,  Parikh H,  Patel AV,  Peeters PH,  Rajkovic A,  Riboli E,  Rodriguez L,  Seminara D,  Shu XO,  Thomas G,  Tjønneland A,  Tobias GS,  Trichopoulos D,  Van Den Eeden SK,  Virtamo J,  Wactawski-Wende J,  Wang Z,  Wolpin BM,  Yu H,  Yu K,  Zeleniuch-Jacquotte A,  Fraumeni JF Jr,  Hoover RN,  Hartge P,  Chanock SJ
Nat Genet 2010 Mar;42(3):224-8
PubMed ID: 20101243
PMC ID: PMC2853179
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Inherited genetic variant predisposes to aggressive but not indolent prostate cancer.

Xu J,  Zheng SL,  Isaacs SD,  Wiley KE,  Wiklund F,  Sun J,  Kader AK,  Li G,  Purcell LD,  Kim ST,  Hsu FC,  Stattin P,  Hugosson J,  Adolfsson J,  Walsh PC,  Trent JM,  Duggan D,  Carpten J,  Grönberg H,  Isaacs WB
Proc Natl Acad Sci U S A 2010 Feb 2;107(5):2136-40
PubMed ID: 20080650
PMC ID: PMC2836698
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Pancreatic cancer risk and ABO blood group alleles: results from the pancreatic cancer cohort consortium.

Wolpin BM,  Kraft P,  Gross M,  Helzlsouer K,  Bueno-de-Mesquita HB,  Steplowski E,  Stolzenberg-Solomon RZ,  Arslan AA,  Jacobs EJ,  Lacroix A,  Petersen G,  Zheng W,  Albanes D,  Allen NE,  Amundadottir L,  Anderson G,  Boutron-Ruault MC,  Buring JE,  Canzian F,  Chanock SJ,  Clipp S,  Gaziano JM,  Giovannucci EL,  Hallmans G,  Hankinson SE,  Hoover RN,  Hunter DJ,  Hutchinson A,  Jacobs K,  Kooperberg C,  Lynch SM,  Mendelsohn JB,  Michaud DS,  Overvad K,  Patel AV,  Rajkovic A,  Sanchéz MJ,  Shu XO,  Slimani N,  Thomas G,  Tobias GS,  Trichopoulos D,  Vineis P,  Virtamo J,  Wactawski-Wende J,  Yu K,  Zeleniuch-Jacquotte A,  Hartge P,  Fuchs CS
Cancer Res 2010 Feb 1;70(3):1015-23
PubMed ID: 20103627
PMC ID: PMC2943735
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Folate intake, post-folic acid grain fortification, and pancreatic cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Oaks BM,  Dodd KW,  Meinhold CL,  Jiao L,  Church TR,  Stolzenberg-Solomon RZ
Am J Clin Nutr 2010 Feb;91(2):449-55
PubMed ID: 20007302
PMC ID: PMC2806895
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Prostate cancer: to screen or not to screen?

Shteynshlyuger A,  Andriole GL
Urol Clin North Am 2010 Feb;37(1):1-9, Table of Contents
PubMed ID: 20152514
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

A comprehensive resequence analysis of the KLK15-KLK3-KLK2 locus on chromosome 19q13.33.

Parikh H,  Deng Z,  Yeager M,  Boland J,  Matthews C,  Jia J,  Collins I,  White A,  Burdett L,  Hutchinson A,  Qi L,  Bacior JA,  Lonsberry V,  Rodesch MJ,  Jeddeloh JA,  Albert TJ,  Halvensleben HA,  Harkins TT,  Ahn J,  Berndt SI,  Chatterjee N,  Hoover R,  Thomas G,  Hunter DJ,  Hayes RB,  Chanock SJ,  Amundadottir L
Hum Genet 2010 Jan;127(1):91-9
PubMed ID: 19823874
PMC ID: PMC2793378
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Utilization of surveillance colonoscopy in community practice.

Schoen RE,  Pinsky PF,  Weissfeld JL,  Yokochi LA,  Reding DJ,  Hayes RB,  Church T,  Yurgalevich S,  Doria-Rose VP,  Hickey T,  Riley T,  Berg CD
Gastroenterology 2010 Jan;138(1):73-81
PubMed ID: 19818779
PMC ID: PMC2813330
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Xenobiotic metabolizing genes, meat-related exposures, and risk of advanced colorectal adenoma.

Ferrucci LM,  Cross AJ,  Gunter MJ,  Ahn J,  Mayne ST,  Ma X,  Chanock SJ,  Yeager M,  Graubard BI,  Berndt SI,  Huang WY,  Hayes RB,  Sinha R
World Rev Nutr Diet 2010;101:34-45
PubMed ID: 20436251
PMC ID: PMC3051350
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Evidence of serum immunoglobulin abnormalities up to 9.8 years before diagnosis of chronic lymphocytic leukemia: a prospective study.

Tsai HT,  Caporaso NE,  Kyle RA,  Katzmann JA,  Dispenzieri A,  Hayes RB,  Marti GE,  Albitar M,  Ghia P,  Rajkumar SV,  Landgren O
Blood 2009 Dec 3;114(24):4928-32
PubMed ID: 19828698
PMC ID: PMC2788972
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Comprehensive resequence analysis of a 97 kb region of chromosome 10q11.2 containing the MSMB gene associated with prostate cancer.

Yeager M,  Deng Z,  Boland J,  Matthews C,  Bacior J,  Lonsberry V,  Hutchinson A,  Burdett LA,  Qi L,  Jacobs KB,  Gonzalez-Bosquet J,  Berndt SI,  Hayes RB,  Hoover RN,  Thomas G,  Hunter DJ,  Dean M,  Chanock SJ
Hum Genet 2009 Dec;126(6):743-50
PubMed ID: 19644707
PMC ID: PMC2778717
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

High-throughput single nucleotide polymorphism genotyping using nanofluidic Dynamic Arrays.

Wang J,  Lin M,  Crenshaw A,  Hutchinson A,  Hicks B,  Yeager M,  Berndt S,  Huang WY,  Hayes RB,  Chanock SJ,  Jones RC,  Ramakrishnan R
BMC Genomics 2009 Nov 28;10:561
PubMed ID: 19943955
PMC ID: PMC2789104
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

A genome-wide association study of lung cancer identifies a region of chromosome 5p15 associated with risk for adenocarcinoma.

Landi MT,  Chatterjee N,  Yu K,  Goldin LR,  Goldstein AM,  Rotunno M,  Mirabello L,  Jacobs K,  Wheeler W,  Yeager M,  Bergen AW,  Li Q,  Consonni D,  Pesatori AC,  Wacholder S,  Thun M,  Diver R,  Oken M,  Virtamo J,  Albanes D,  Wang Z,  Burdette L,  Doheny KF,  Pugh EW,  Laurie C,  Brennan P,  Hung R,  Gaborieau V,  McKay JD,  Lathrop M,  McLaughlin J,  Wang Y,  Tsao MS,  Spitz MR,  Wang Y,  Krokan H,  Vatten L,  Skorpen F,  Arnesen E,  Benhamou S,  Bouchard C,  Metspalu A,  Vooder T,  Nelis M,  Välk K,  Field JK,  Chen C,  Goodman G,  Sulem P,  Thorleifsson G,  Rafnar T,  Eisen T,  Sauter W,  Rosenberger A,  Bickeböller H,  Risch A,  Chang-Claude J,  Wichmann HE,  Stefansson K,  Houlston R,  Amos CI,  Fraumeni JF Jr,  Savage SA,  Bertazzi PA,  Tucker MA,  Chanock S,  Caporaso NE
Am J Hum Genet 2009 Nov;85(5):679-91
PubMed ID: 19836008
PMC ID: PMC2775843
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Energy intake and risk of postmenopausal breast cancer: an expanded analysis in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial (PLCO) cohort.

Sue LY,  Schairer C,  Ma X,  Williams C,  Chang SC,  Miller AB,  McCarty CA,  Willcox BJ,  Ziegler RG
Cancer Epidemiol Biomarkers Prev 2009 Nov;18(11):2842-50
PubMed ID: 19843674
PMC ID: PMC2783562
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Estimation of absolute risk for prostate cancer using genetic markers and family history.

Xu J,  Sun J,  Kader AK,  Lindström S,  Wiklund F,  Hsu FC,  Johansson JE,  Zheng SL,  Thomas G,  Hayes RB,  Kraft P,  Hunter DJ,  Chanock SJ,  Isaacs WB,  Grönberg H
Prostate 2009 Oct 1;69(14):1565-72
PubMed ID: 19562736
PMC ID: PMC2793526
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

CYP19A1 genetic variation in relation to prostate cancer risk and circulating sex hormone concentrations in men from the Breast and Prostate Cancer Cohort Consortium.

Travis RC,  Schumacher F,  Hirschhorn JN,  Kraft P,  Allen NE,  Albanes D,  Berglund G,  Berndt SI,  Boeing H,  Bueno-de-Mesquita HB,  Calle EE,  Chanock S,  Dunning AM,  Hayes R,  Feigelson HS,  Gaziano JM,  Giovannucci E,  Haiman CA,  Henderson BE,  Kaaks R,  Kolonel LN,  Ma J,  Rodriguez L,  Riboli E,  Stampfer M,  Stram DO,  Thun MJ,  Tjønneland A,  Trichopoulos D,  Vineis P,  Virtamo J,  Le Marchand L,  Hunter DJ
Cancer Epidemiol Biomarkers Prev 2009 Oct;18(10):2734-44
PubMed ID: 19789370
PMC ID: PMC2812905
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

A prospective study of serum soluble CD30 concentration and risk of non-Hodgkin lymphoma.

Purdue MP,  Lan Q,  Martinez-Maza O,  Oken MM,  Hocking W,  Huang WY,  Baris D,  Conde B,  Rothman N
Blood 2009 Sep 24;114(13):2730-2
PubMed ID: 19638620
PMC ID: PMC2756127
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Genome-wide association study identifies variants in the ABO locus associated with susceptibility to pancreatic cancer.

Amundadottir L,  Kraft P,  Stolzenberg-Solomon RZ,  Fuchs CS,  Petersen GM,  Arslan AA,  Bueno-de-Mesquita HB,  Gross M,  Helzlsouer K,  Jacobs EJ,  LaCroix A,  Zheng W,  Albanes D,  Bamlet W,  Berg CD,  Berrino F,  Bingham S,  Buring JE,  Bracci PM,  Canzian F,  Clavel-Chapelon F,  Clipp S,  Cotterchio M,  de Andrade M,  Duell EJ,  Fox JW Jr,  Gallinger S,  Gaziano JM,  Giovannucci EL,  Goggins M,  González CA,  Hallmans G,  Hankinson SE,  Hassan M,  Holly EA,  Hunter DJ,  Hutchinson A,  Jackson R,  Jacobs KB,  Jenab M,  Kaaks R,  Klein AP,  Kooperberg C,  Kurtz RC,  Li D,  Lynch SM,  Mandelson M,  McWilliams RR,  Mendelsohn JB,  Michaud DS,  Olson SH,  Overvad K,  Patel AV,  Peeters PH,  Rajkovic A,  Riboli E,  Risch HA,  Shu XO,  Thomas G,  Tobias GS,  Trichopoulos D,  Van Den Eeden SK,  Virtamo J,  Wactawski-Wende J,  Wolpin BM,  Yu H,  Yu K,  Zeleniuch-Jacquotte A,  Chanock SJ,  Hartge P,  Hoover RN
Nat Genet 2009 Sep;41(9):986-90
PubMed ID: 19648918
PMC ID: PMC2839871
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Cigarette smoking and pancreatic cancer: a pooled analysis from the pancreatic cancer cohort consortium.

Lynch SM,  Vrieling A,  Lubin JH,  Kraft P,  Mendelsohn JB,  Hartge P,  Canzian F,  Steplowski E,  Arslan AA,  Gross M,  Helzlsouer K,  Jacobs EJ,  LaCroix A,  Petersen G,  Zheng W,  Albanes D,  Amundadottir L,  Bingham SA,  Boffetta P,  Boutron-Ruault MC,  Chanock SJ,  Clipp S,  Hoover RN,  Jacobs K,  Johnson KC,  Kooperberg C,  Luo J,  Messina C,  Palli D,  Patel AV,  Riboli E,  Shu XO,  Rodriguez Suarez L,  Thomas G,  Tjønneland A,  Tobias GS,  Tong E,  Trichopoulos D,  Virtamo J,  Ye W,  Yu K,  Zeleniuch-Jacquette A,  Bueno-de-Mesquita HB,  Stolzenberg-Solomon RZ
Am J Epidemiol 2009 Aug 15;170(4):403-13
PubMed ID: 19561064
PMC ID: PMC2733861
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Height and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.

Ahn J,  Moore SC,  Albanes D,  Huang WY,  Leitzmann MF,  Hayes RB,  Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial Project Team
Br J Cancer 2009 Aug 4;101(3):522-5
PubMed ID: 19568244
PMC ID: PMC2720230
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Reliability and accuracy of the endoscopic appearance in the identification of aberrant crypt foci.

Gupta AK,  Pinsky P,  Rall C,  Mutch M,  Dry S,  Seligson D,  Schoen RE
Gastrointest Endosc 2009 Aug;70(2):322-30
PubMed ID: 19539919
PMC ID: PMC2727598
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

The association between leukocyte telomere length and cigarette smoking, dietary and physical variables, and risk of prostate cancer.

Mirabello L,  Huang WY,  Wong JY,  Chatterjee N,  Reding D,  Crawford ED,  De Vivo I,  Hayes RB,  Savage SA
Aging Cell 2009 Aug;8(4):405-13
PubMed ID: 19493248
PMC ID: PMC2742954
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Intake of meat, meat mutagens, and iron and the risk of breast cancer in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Ferrucci LM,  Cross AJ,  Graubard BI,  Brinton LA,  McCarty CA,  Ziegler RG,  Ma X,  Mayne ST,  Sinha R
Br J Cancer 2009 Jul 7;101(1):178-84
PubMed ID: 19513076
PMC ID: PMC2713710
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Genetic background comparison using distance-based regression, with applications in population stratification evaluation and adjustment.

Li Q,  Wacholder S,  Hunter DJ,  Hoover RN,  Chanock S,  Thomas G,  Yu K
Genet Epidemiol 2009 Jul;33(5):432-41
PubMed ID: 19140130
PMC ID: PMC2706300
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Fine-mapping and family-based association analyses of prostate cancer risk variants at Xp11.

Lu L,  Sun J,  Isaacs SD,  Wiley KE,  Smith S,  Pruett K,  Zhu Y,  Zhang Z,  Wiklund F,  Grönberg H,  Walsh PC,  Chang BL,  Zheng SL,  Isaacs WB,  Xu J
Cancer Epidemiol Biomarkers Prev 2009 Jul;18(7):2132-6
PubMed ID: 19549809
PMC ID: PMC2795389
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Airway wall attenuation: a biomarker of airway disease in subjects with COPD.

Washko GR,  Dransfield MT,  Estépar RS,  Diaz A,  Matsuoka S,  Yamashiro T,  Hatabu H,  Silverman EK,  Bailey WC,  Reilly JJ
J Appl Physiol (1985) 2009 Jul;107(1):185-91
PubMed ID: 19407254
PMC ID: PMC2711787
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Two independent prostate cancer risk-associated Loci at 11q13.

Zheng SL,  Stevens VL,  Wiklund F,  Isaacs SD,  Sun J,  Smith S,  Pruett K,  Wiley KE,  Kim ST,  Zhu Y,  Zhang Z,  Hsu FC,  Turner AR,  Johansson JE,  Liu W,  Kim JW,  Chang BL,  Duggan D,  Carpten J,  Rodriguez C,  Isaacs W,  Grönberg H,  Xu J
Cancer Epidemiol Biomarkers Prev 2009 Jun;18(6):1815-20
PubMed ID: 19505914
PMC ID: PMC2802212
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Monoclonal gammopathy of undetermined significance (MGUS) consistently precedes multiple myeloma: a prospective study.

Landgren O,  Kyle RA,  Pfeiffer RM,  Katzmann JA,  Caporaso NE,  Hayes RB,  Dispenzieri A,  Kumar S,  Clark RJ,  Baris D,  Hoover R,  Rajkumar SV
Blood 2009 May 28;113(22):5412-7
PubMed ID: 19179464
PMC ID: PMC2689042
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

A web server for inferring the human N-acetyltransferase-2 (NAT2) enzymatic phenotype from NAT2 genotype.

Kuznetsov IB,  McDuffie M,  Moslehi R
Bioinformatics 2009 May 1;25(9):1185-6
PubMed ID: 19261719
PMC ID: PMC2672629
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Newly discovered breast cancer susceptibility loci on 3p24 and 17q23.2.

Ahmed S,  Thomas G,  Ghoussaini M,  Healey CS,  Humphreys MK,  Platte R,  Morrison J,  Maranian M,  Pooley KA,  Luben R,  Eccles D,  Evans DG,  Fletcher O,  Johnson N,  dos Santos Silva I,  Peto J,  Stratton MR,  Rahman N,  Jacobs K,  Prentice R,  Anderson GL,  Rajkovic A,  Curb JD,  Ziegler RG,  Berg CD,  Buys SS,  McCarty CA,  Feigelson HS,  Calle EE,  Thun MJ,  Diver WR,  Bojesen S,  Nordestgaard BG,  Flyger H,  Dörk T,  Schürmann P,  Hillemanns P,  Karstens JH,  Bogdanova NV,  Antonenkova NN,  Zalutsky IV,  Bermisheva M,  Fedorova S,  Khusnutdinova E,  SEARCH,  Kang D,  Yoo KY,  Noh DY,  Ahn SH,  Devilee P,  van Asperen CJ,  Tollenaar RA,  Seynaeve C,  Garcia-Closas M,  Lissowska J,  Brinton L,  Peplonska B,  Nevanlinna H,  Heikkinen T,  Aittomäki K,  Blomqvist C,  Hopper JL,  Southey MC,  Smith L,  Spurdle AB,  Schmidt MK,  Broeks A,  van Hien RR,  Cornelissen S,  Milne RL,  Ribas G,  González-Neira A,  Benitez J,  Schmutzler RK,  Burwinkel B,  Bartram CR,  Meindl A,  Brauch H,  Justenhoven C,  Hamann U,  GENICA Consortium,  Chang-Claude J,  Hein R,  Wang-Gohrke S,  Lindblom A,  Margolin S,  Mannermaa A,  Kosma VM,  Kataja V,  Olson JE,  Wang X,  Fredericksen Z,  Giles GG,  Severi G,  Baglietto L,  English DR,  Hankinson SE,  Cox DG,  Kraft P,  Vatten LJ,  Hveem K,  Kumle M,  Sigurdson A,  Doody M,  Bhatti P,  Alexander BH,  Hooning MJ,  van den Ouweland AM,  Oldenburg RA,  Schutte M,  Hall P,  Czene K,  Liu J,  Li Y,  Cox A,  Elliott G,  Brock I,  Reed MW,  Shen CY,  Yu JC,  Hsu GC,  Chen ST,  Anton-Culver H,  Ziogas A,  Andrulis IL,  Knight JA,  kConFab,  Australian Ovarian Cancer Study Group,  Beesley J,  Goode EL,  Couch F,  Chenevix-Trench G,  Hoover RN,  Ponder BA,  Hunter DJ,  Pharoah PD,  Dunning AM,  Chanock SJ,  Easton DF
Nat Genet 2009 May;41(5):585-90
PubMed ID: 19330027
PMC ID: PMC2748125
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Vitamin D-related genes, serum vitamin D concentrations and prostate cancer risk.

Ahn J,  Albanes D,  Berndt SI,  Peters U,  Chatterjee N,  Freedman ND,  Abnet CC,  Huang WY,  Kibel AS,  Crawford ED,  Weinstein SJ,  Chanock SJ,  Schatzkin A,  Hayes RB,  Prostate, Lung, Colorectal and Ovarian Trial Project Team
Carcinogenesis 2009 May;30(5):769-76
PubMed ID: 19255064
PMC ID: PMC2675652
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Genetic variants in frizzled-related protein (FRZB) and the risk of colorectal neoplasia.

Berndt SI,  Huang WY,  Yeager M,  Weissfeld JL,  Chanock SJ,  Hayes RB
Cancer Causes Control 2009 May;20(4):487-90
PubMed ID: 19067193
PMC ID: PMC2667207
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Cumulative incidence of false-positive results in repeated, multimodal cancer screening.

Croswell JM,  Kramer BS,  Kreimer AR,  Prorok PC,  Xu JL,  Baker SG,  Fagerstrom R,  Riley TL,  Clapp JD,  Berg CD,  Gohagan JK,  Andriole GL,  Chia D,  Church TR,  Crawford ED,  Fouad MN,  Gelmann EP,  Lamerato L,  Reding DJ,  Schoen RE
Ann Fam Med 2009 May-Jun;7(3):212-22
PubMed ID: 19433838
PMC ID: PMC2682972
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening TrialChemopreventive Agent Development

A multicenter study of prevalence and risk factors for aberrant crypt foci.

Mutch MG,  Schoen RE,  Fleshman JW,  Rall CJ,  Dry S,  Seligson D,  Charabaty A,  Chia D,  Umar A,  Viner J,  Hawk E,  Pinsky PF
Clin Gastroenterol Hepatol 2009 May;7(5):568-74
PubMed ID: 19418605
PMC ID: not available
Groups or Programs: Gastrointestinal and Other CancersEarly DetectionPLCO Cancer Screening Trial

A multistage genome-wide association study in breast cancer identifies two new risk alleles at 1p11.2 and 14q24.1 (RAD51L1).

Thomas G,  Jacobs KB,  Kraft P,  Yeager M,  Wacholder S,  Cox DG,  Hankinson SE,  Hutchinson A,  Wang Z,  Yu K,  Chatterjee N,  Garcia-Closas M,  Gonzalez-Bosquet J,  Prokunina-Olsson L,  Orr N,  Willett WC,  Colditz GA,  Ziegler RG,  Berg CD,  Buys SS,  McCarty CA,  Feigelson HS,  Calle EE,  Thun MJ,  Diver R,  Prentice R,  Jackson R,  Kooperberg C,  Chlebowski R,  Lissowska J,  Peplonska B,  Brinton LA,  Sigurdson A,  Doody M,  Bhatti P,  Alexander BH,  Buring J,  Lee IM,  Vatten LJ,  Hveem K,  Kumle M,  Hayes RB,  Tucker M,  Gerhard DS,  Fraumeni JF Jr,  Hoover RN,  Chanock SJ,  Hunter DJ
Nat Genet 2009 May;41(5):579-84
PubMed ID: 19330030
PMC ID: PMC2928646
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Nitric oxide synthase gene polymorphisms and prostate cancer risk.

Lee KM,  Kang D,  Park SK,  Berndt SI,  Reding D,  Chatterjee N,  Chanock S,  Huang WY,  Hayes RB
Carcinogenesis 2009 Apr;30(4):621-5
PubMed ID: 19168583
PMC ID: PMC2664454
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Results from four rounds of ovarian cancer screening in a randomized trial.

Partridge E,  Kreimer AR,  Greenlee RT,  Williams C,  Xu JL,  Church TR,  Kessel B,  Johnson CC,  Weissfeld JL,  Isaacs C,  Andriole GL,  Ogden S,  Ragard LR,  Buys SS,  PLCO Project Team
Obstet Gynecol 2009 Apr;113(4):775-82
PubMed ID: 19305319
PMC ID: PMC2728067
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Serum retinol and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial.

Schenk JM,  Riboli E,  Chatterjee N,  Leitzmann MF,  Ahn J,  Albanes D,  Reding DJ,  Wang Y,  Friesen MD,  Hayes RB,  Peters U
Cancer Epidemiol Biomarkers Prev 2009 Apr;18(4):1227-31
PubMed ID: 19336558
PMC ID: PMC2717001
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Mortality results from a randomized prostate-cancer screening trial.

Andriole GL,  Crawford ED,  Grubb RL 3rd,  Buys SS,  Chia D,  Church TR,  Fouad MN,  Gelmann EP,  Kvale PA,  Reding DJ,  Weissfeld JL,  Yokochi LA,  O'Brien B,  Clapp JD,  Rathmell JM,  Riley TL,  Hayes RB,  Kramer BS,  Izmirlian G,  Miller AB,  Pinsky PF,  Prorok PC,  Gohagan JK,  Berg CD,  PLCO Project Team
N Engl J Med 2009 Mar 26;360(13):1310-9
PubMed ID: 19297565
PMC ID: PMC2944770
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening TrialChemopreventive Agent Development

Screening for prostate cancer--the controversy that refuses to die.

Barry MJ
N Engl J Med 2009 Mar 26;360(13):1351-4
PubMed ID: 19297564
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Breast cancer epidemiology according to recognized breast cancer risk factors in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Cohort.

Lacey JV Jr,  Kreimer AR,  Buys SS,  Marcus PM,  Chang SC,  Leitzmann MF,  Hoover RN,  Prorok PC,  Berg CD,  Hartge P,  Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial Project Team
BMC Cancer 2009 Mar 17;9:84
PubMed ID: 19292893
PMC ID: PMC2670317
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Xenobiotic metabolizing gene variants, dietary heterocyclic amine intake, and risk of prostate cancer.

Koutros S,  Berndt SI,  Sinha R,  Ma X,  Chatterjee N,  Alavanja MC,  Zheng T,  Huang WY,  Hayes RB,  Cross AJ
Cancer Res 2009 Mar 1;69(5):1877-84
PubMed ID: 19223546
PMC ID: PMC2662592
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Serum prostate-specific antigen hemodilution among obese men undergoing screening in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Grubb RL 3rd,  Black A,  Izmirlian G,  Hickey TP,  Pinsky PF,  Mabie JE,  Riley TL,  Ragard LR,  Prorok PC,  Berg CD,  Crawford ED,  Church TR,  Andriole GL Jr,  PLCO Project Team
Cancer Epidemiol Biomarkers Prev 2009 Mar;18(3):748-51
PubMed ID: 19258472
PMC ID: not available
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Adipokine genes and prostate cancer risk.

Moore SC,  Leitzmann MF,  Albanes D,  Weinstein SJ,  Snyder K,  Virtamo J,  Ahn J,  Mayne ST,  Yu H,  Peters U,  Gunter MJ
Int J Cancer 2009 Feb 15;124(4):869-76
PubMed ID: 19035456
PMC ID: PMC2879625
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Serum vitamin D and risk of pancreatic cancer in the prostate, lung, colorectal, and ovarian screening trial.

Stolzenberg-Solomon RZ,  Hayes RB,  Horst RL,  Anderson KE,  Hollis BW,  Silverman DT
Cancer Res 2009 Feb 15;69(4):1439-47
PubMed ID: 19208842
PMC ID: PMC3052200
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

B-cell clones as early markers for chronic lymphocytic leukemia.

Landgren O,  Albitar M,  Ma W,  Abbasi F,  Hayes RB,  Ghia P,  Marti GE,  Caporaso NE
N Engl J Med 2009 Feb 12;360(7):659-67
PubMed ID: 19213679
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Recruitment methods employed in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Gren L,  Broski K,  Childs J,  Cordes J,  Engelhard D,  Gahagan B,  Gamito E,  Gardner V,  Geisser M,  Higgins D,  Jenkins V,  Lamerato L,  Lappe K,  Lowery H,  McGuire C,  Miedzinski M,  Ogden S,  Tenorio S,  Watt G,  Wohlers B,  Marcus P
Clin Trials 2009 Feb;6(1):52-9
PubMed ID: 19254935
PMC ID: PMC4651181
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

SLC6A3 and body mass index in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Azzato EM,  Morton LM,  Bergen AW,  Wang SS,  Chatterjee N,  Kvale P,  Yeager M,  Hayes RB,  Chanock SJ,  Caporaso NE
BMC Med Genet 2009 Jan 30;10:9
PubMed ID: 19183461
PMC ID: PMC2640369
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

A prospectively measured serum biomarker for a tobacco-specific carcinogen and lung cancer in smokers.

Church TR,  Anderson KE,  Caporaso NE,  Geisser MS,  Le CT,  Zhang Y,  Benoit AR,  Carmella SG,  Hecht SS
Cancer Epidemiol Biomarkers Prev 2009 Jan;18(1):260-6
PubMed ID: 19124507
PMC ID: PMC3513324
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

The yield of surveillance colonoscopy by adenoma history and time to examination.

Pinsky PF,  Schoen RE,  Weissfeld JL,  Church T,  Yokochi LA,  Doria-Rose VP,  Prorok P
Clin Gastroenterol Hepatol 2009 Jan;7(1):86-92
PubMed ID: 18829395
PMC ID: not available
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Six new loci associated with body mass index highlight a neuronal influence on body weight regulation.

Willer CJ,  Speliotes EK,  Loos RJ,  Li S,  Lindgren CM,  Heid IM,  Berndt SI,  Elliott AL,  Jackson AU,  Lamina C,  Lettre G,  Lim N,  Lyon HN,  McCarroll SA,  Papadakis K,  Qi L,  Randall JC,  Roccasecca RM,  Sanna S,  Scheet P,  Weedon MN,  Wheeler E,  Zhao JH,  Jacobs LC,  Prokopenko I,  Soranzo N,  Tanaka T,  Timpson NJ,  Almgren P,  Bennett A,  Bergman RN,  Bingham SA,  Bonnycastle LL,  Brown M,  Burtt NP,  Chines P,  Coin L,  Collins FS,  Connell JM,  Cooper C,  Smith GD,  Dennison EM,  Deodhar P,  Elliott P,  Erdos MR,  Estrada K,  Evans DM,  Gianniny L,  Gieger C,  Gillson CJ,  Guiducci C,  Hackett R,  Hadley D,  Hall AS,  Havulinna AS,  Hebebrand J,  Hofman A,  Isomaa B,  Jacobs KB,  Johnson T,  Jousilahti P,  Jovanovic Z,  Khaw KT,  Kraft P,  Kuokkanen M,  Kuusisto J,  Laitinen J,  Lakatta EG,  Luan J,  Luben RN,  Mangino M,  McArdle WL,  Meitinger T,  Mulas A,  Munroe PB,  Narisu N,  Ness AR,  Northstone K,  O'Rahilly S,  Purmann C,  Rees MG,  Ridderstråle M,  Ring SM,  Rivadeneira F,  Ruokonen A,  Sandhu MS,  Saramies J,  Scott LJ,  Scuteri A,  Silander K,  Sims MA,  Song K,  Stephens J,  Stevens S,  Stringham HM,  Tung YC,  Valle TT,  Van Duijn CM,  Vimaleswaran KS,  Vollenweider P,  Waeber G,  Wallace C,  Watanabe RM,  Waterworth DM,  Watkins N,  Wellcome Trust Case Control Consortium,  Witteman JC,  Zeggini E,  Zhai G,  Zillikens MC,  Altshuler D,  Caulfield MJ,  Chanock SJ,  Farooqi IS,  Ferrucci L,  Guralnik JM,  Hattersley AT,  Hu FB,  Jarvelin MR,  Laakso M,  Mooser V,  Ong KK,  Ouwehand WH,  Salomaa V,  Samani NJ,  Spector TD,  Tuomi T,  Tuomilehto J,  Uda M,  Uitterlinden AG,  Wareham NJ,  Deloukas P,  Frayling TM,  Groop LC,  Hayes RB,  Hunter DJ,  Mohlke KL,  Peltonen L,  Schlessinger D,  Strachan DP,  Wichmann HE,  McCarthy MI,  Boehnke M,  Barroso I,  Abecasis GR,  Hirschhorn JN,  Genetic Investigation of ANthropometric Traits Consortium
Nat Genet 2009 Jan;41(1):25-34
PubMed ID: 19079261
PMC ID: PMC2695662
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Genome-wide and candidate gene association study of cigarette smoking behaviors.

Caporaso N,  Gu F,  Chatterjee N,  Sheng-Chih J,  Yu K,  Yeager M,  Chen C,  Jacobs K,  Wheeler W,  Landi MT,  Ziegler RG,  Hunter DJ,  Chanock S,  Hankinson S,  Kraft P,  Bergen AW
PLoS One 2009;4(2):e4653
PubMed ID: 19247474
PMC ID: PMC2644817
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Prostate cancer screening in the Prostate, Lung, Colorectal and Ovarian cancer screening trial: update on findings from the initial four rounds of screening in a randomized trial.

Grubb RL 3rd,  Pinsky PF,  Greenlee RT,  Izmirlian G,  Miller AB,  Hickey TP,  Riley TL,  Mabie JE,  Levin DL,  Chia D,  Kramer BS,  Reding DJ,  Church TR,  Yokochi LA,  Kvale PA,  Weissfeld JL,  Urban DA,  Buys SS,  Gelmann EP,  Ragard LR,  Crawford ED,  Prorok PC,  Gohagan JK,  Berg CD,  Andriole GL
BJU Int 2008 Dec;102(11):1524-30
PubMed ID: 19035857
PMC ID: not available
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Diabetes mellitus and prostate cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Leitzmann MF,  Ahn J,  Albanes D,  Hsing AW,  Schatzkin A,  Chang SC,  Huang WY,  Weiss JM,  Danforth KN,  Grubb RL 3rd,  Andriole GL,  Prostate, Lung, Colorectal, and Ovarian Trial Project Team
Cancer Causes Control 2008 Dec;19(10):1267-76
PubMed ID: 18618278
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Lung cancer risk following detection of pulmonary scarring by chest radiography in the prostate, lung, colorectal, and ovarian cancer screening trial.

Yu YY,  Pinsky PF,  Caporaso NE,  Chatterjee N,  Baumgarten M,  Langenberg P,  Furuno JP,  Lan Q,  Engels EA
Arch Intern Med 2008 Nov 24;168(21):2326-32; discussion 2332
PubMed ID: 19029496
PMC ID: PMC2866505
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Pooled analysis of genetic variation at chromosome 8q24 and colorectal neoplasia risk.

Berndt SI,  Potter JD,  Hazra A,  Yeager M,  Thomas G,  Makar KW,  Welch R,  Cross AJ,  Huang WY,  Schoen RE,  Giovannucci E,  Chan AT,  Chanock SJ,  Peters U,  Hunter DJ,  Hayes RB
Hum Mol Genet 2008 Sep 1;17(17):2665-72
PubMed ID: 18535017
PMC ID: PMC2561994
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Variation in KLK genes, prostate-specific antigen and risk of prostate cancer.

Ahn J,  Berndt SI,  Wacholder S,  Kraft P,  Kibel AS,  Yeager M,  Albanes D,  Giovannucci E,  Stampfer MJ,  Virtamo J,  Thun MJ,  Feigelson HS,  Cancel-Tassin G,  Cussenot O,  Thomas G,  Hunter DJ,  Fraumeni JF Jr,  Hoover RN,  Chanock SJ,  Hayes RB
Nat Genet 2008 Sep;40(9):1032-6
PubMed ID: 19165914
PMC ID: PMC3086200
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Sexually transmissible infections and prostate cancer risk.

Huang WY,  Hayes R,  Pfeiffer R,  Viscidi RP,  Lee FK,  Wang YF,  Reding D,  Whitby D,  Papp JR,  Rabkin CS
Cancer Epidemiol Biomarkers Prev 2008 Sep;17(9):2374-81
PubMed ID: 18768506
PMC ID: PMC2559953
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

The epidemiology of CA-125 in women without evidence of ovarian cancer in the Prostate, Lung, Colorectal and Ovarian Cancer (PLCO) Screening Trial.

Johnson CC,  Kessel B,  Riley TL,  Ragard LR,  Williams CR,  Xu JL,  Buys SS,  Prostate, Lung, Colorectal and Ovarian Cancer Project Team
Gynecol Oncol 2008 Sep;110(3):383-9
PubMed ID: 18586313
PMC ID: PMC3744195
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Exploiting gene-environment independence for analysis of case-control studies: an empirical Bayes-type shrinkage estimator to trade-off between bias and efficiency.

Mukherjee B,  Chatterjee N
Biometrics 2008 Sep;64(3):685-94
PubMed ID: 18162111
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

IGF-1, IGFBP-1, and IGFBP-3 polymorphisms predict circulating IGF levels but not breast cancer risk: findings from the Breast and Prostate Cancer Cohort Consortium (BPC3).

Patel AV,  Cheng I,  Canzian F,  Le Marchand L,  Thun MJ,  Berg CD,  Buring J,  Calle EE,  Chanock S,  Clavel-Chapelon F,  Cox DG,  Dorronsoro M,  Dossus L,  Haiman CA,  Hankinson SE,  Henderson BE,  Hoover R,  Hunter DJ,  Kaaks R,  Kolonel LN,  Kraft P,  Linseisen J,  Lund E,  Manjer J,  McCarty C,  Peeters PH,  Pike MC,  Pollak M,  Riboli E,  Stram DO,  Tjonneland A,  Travis RC,  Trichopoulos D,  Tumino R,  Yeager M,  Ziegler RG,  Feigelson HS,  Breast and Prostate Cancer Cohort Consortium
PLoS One 2008 Jul 2;3(7):e2578
PubMed ID: 18596909
PMC ID: PMC2440354
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Serum vitamin D concentration and prostate cancer risk: a nested case-control study.

Ahn J,  Peters U,  Albanes D,  Purdue MP,  Abnet CC,  Chatterjee N,  Horst RL,  Hollis BW,  Huang WY,  Shikany JM,  Hayes RB,  Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Project Team
J Natl Cancer Inst 2008 Jun 4;100(11):796-804
PubMed ID: 18505967
PMC ID: PMC3703748
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Common variants near MC4R are associated with fat mass, weight and risk of obesity.

Loos RJ,  Lindgren CM,  Li S,  Wheeler E,  Zhao JH,  Prokopenko I,  Inouye M,  Freathy RM,  Attwood AP,  Beckmann JS,  Berndt SI,  Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial,  Jacobs KB,  Chanock SJ,  Hayes RB,  Bergmann S,  Bennett AJ,  Bingham SA,  Bochud M,  Brown M,  Cauchi S,  Connell JM,  Cooper C,  Smith GD,  Day I,  Dina C,  De S,  Dermitzakis ET,  Doney AS,  Elliott KS,  Elliott P,  Evans DM,  Sadaf Farooqi I,  Froguel P,  Ghori J,  Groves CJ,  Gwilliam R,  Hadley D,  Hall AS,  Hattersley AT,  Hebebrand J,  Heid IM,  KORA,  Lamina C,  Gieger C,  Illig T,  Meitinger T,  Wichmann HE,  Herrera B,  Hinney A,  Hunt SE,  Jarvelin MR,  Johnson T,  Jolley JD,  Karpe F,  Keniry A,  Khaw KT,  Luben RN,  Mangino M,  Marchini J,  McArdle WL,  McGinnis R,  Meyre D,  Munroe PB,  Morris AD,  Ness AR,  Neville MJ,  Nica AC,  Ong KK,  O'Rahilly S,  Owen KR,  Palmer CN,  Papadakis K,  Potter S,  Pouta A,  Qi L,  Nurses' Health Study,  Randall JC,  Rayner NW,  Ring SM,  Sandhu MS,  Scherag A,  Sims MA,  Song K,  Soranzo N,  Speliotes EK,  Diabetes Genetics Initiative,  Syddall HE,  Teichmann SA,  Timpson NJ,  Tobias JH,  Uda M,  SardiNIA Study,  Vogel CI,  Wallace C,  Waterworth DM,  Weedon MN,  Wellcome Trust Case Control Consortium,  Willer CJ,  FUSION,  Wraight,  Yuan X,  Zeggini E,  Hirschhorn JN,  Strachan DP,  Ouwehand WH,  Caulfield MJ,  Samani NJ,  Frayling TM,  Vollenweider P,  Waeber G,  Mooser V,  Deloukas P,  McCarthy MI,  Wareham NJ,  Barroso I,  Jacobs KB,  Chanock SJ,  Hayes RB,  Lamina C,  Gieger C,  Illig T,  Meitinger T,  Wichmann HE,  Kraft P,  Hankinson SE,  Hunter DJ,  Hu FB,  Lyon HN,  Voight BF,  Ridderstrale M,  Groop L,  Scheet P,  Sanna S,  Abecasis GR,  Albai G,  Nagaraja R,  Schlessinger D,  Jackson AU,  Tuomilehto J,  Collins FS,  Boehnke M,  Mohlke KL
Nat Genet 2008 Jun;40(6):768-75
PubMed ID: 18454148
PMC ID: PMC2669167
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

The natural history of aberrant crypt foci.

Schoen RE,  Mutch M,  Rall C,  Dry SM,  Seligson D,  Umar A,  Pinsky P
Gastrointest Endosc 2008 Jun;67(7):1097-102
PubMed ID: 18178205
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Endogenous sex hormones and the risk of prostate cancer: a prospective study.

Weiss JM,  Huang WY,  Rinaldi S,  Fears TR,  Chatterjee N,  Hsing AW,  Crawford ED,  Andriole GL,  Kaaks R,  Hayes RB
Int J Cancer 2008 May 15;122(10):2345-50
PubMed ID: 18172860
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Effects of baseline comorbidities on cancer screening trial adherence among older African American men.

Ford ME,  Havstad SL,  Fields ME,  Manigo B,  McClary B,  Lamerato L
Cancer Epidemiol Biomarkers Prev 2008 May;17(5):1234-9
PubMed ID: 18463399
PMC ID: PMC3424636
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Identification of ten loci associated with height highlights new biological pathways in human growth.

Lettre G,  Jackson AU,  Gieger C,  Schumacher FR,  Berndt SI,  Sanna S,  Eyheramendy S,  Voight BF,  Butler JL,  Guiducci C,  Illig T,  Hackett R,  Heid IM,  Jacobs KB,  Lyssenko V,  Uda M,  Diabetes Genetics Initiative,  FUSION,  KORA,  Prostate, Lung Colorectal and Ovarian Cancer Screening Trial,  Nurses' Health Study,  SardiNIA,  Boehnke M,  Chanock SJ,  Groop LC,  Hu FB,  Isomaa B,  Kraft P,  Peltonen L,  Salomaa V,  Schlessinger D,  Hunter DJ,  Hayes RB,  Abecasis GR,  Wichmann HE,  Mohlke KL,  Hirschhorn JN
Nat Genet 2008 May;40(5):584-91
PubMed ID: 18391950
PMC ID: PMC2687076
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Variation in the selenoenzyme genes and risk of advanced distal colorectal adenoma.

Peters U,  Chatterjee N,  Hayes RB,  Schoen RE,  Wang Y,  Chanock SJ,  Foster CB
Cancer Epidemiol Biomarkers Prev 2008 May;17(5):1144-54
PubMed ID: 18483336
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Serum levels of vitamin D metabolites and breast cancer risk in the prostate, lung, colorectal, and ovarian cancer screening trial.

Freedman DM,  Chang SC,  Falk RT,  Purdue MP,  Huang WY,  McCarty CA,  Hollis BW,  Graubard BI,  Berg CD,  Ziegler RG
Cancer Epidemiol Biomarkers Prev 2008 Apr;17(4):889-94
PubMed ID: 18381472
PMC ID: PMC4039037
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Recruitment in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial: the first phase of recruitment at Henry Ford Health System.

Lamerato LE,  Marcus PM,  Jacobsen G,  Johnson CC
Cancer Epidemiol Biomarkers Prev 2008 Apr;17(4):827-33
PubMed ID: 18398023
PMC ID: not available
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

TNF polymorphisms and prostate cancer risk.

Danforth KN,  Rodriguez C,  Hayes RB,  Sakoda LC,  Huang WY,  Yu K,  Calle EE,  Jacobs EJ,  Chen BE,  Andriole GL,  Figueroa JD,  Yeager M,  Platz EA,  Michaud DS,  Chanock SJ,  Thun MJ,  Hsing AW
Prostate 2008 Mar 1;68(4):400-7
PubMed ID: 18196539
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Polymorphic variants in PTGS2 and prostate cancer risk: results from two large nested case-control studies.

Danforth KN,  Hayes RB,  Rodriguez C,  Yu K,  Sakoda LC,  Huang WY,  Chen BE,  Chen J,  Andriole GL,  Calle EE,  Jacobs EJ,  Chu LW,  Figueroa JD,  Yeager M,  Platz EA,  Michaud DS,  Chanock SJ,  Thun MJ,  Hsing AW
Carcinogenesis 2008 Mar;29(3):568-72
PubMed ID: 17999989
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Enrollment of racial and ethnic minorities in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Pinsky PF,  Ford M,  Gamito E,  Higgins D,  Jenkins V,  Lamerato L,  Tenorio S,  Marcus PM,  Gohagan JK
J Natl Med Assoc 2008 Mar;100(3):291-8
PubMed ID: 18390022
PMC ID: not available
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Multiple loci identified in a genome-wide association study of prostate cancer.

Thomas G,  Jacobs KB,  Yeager M,  Kraft P,  Wacholder S,  Orr N,  Yu K,  Chatterjee N,  Welch R,  Hutchinson A,  Crenshaw A,  Cancel-Tassin G,  Staats BJ,  Wang Z,  Gonzalez-Bosquet J,  Fang J,  Deng X,  Berndt SI,  Calle EE,  Feigelson HS,  Thun MJ,  Rodriguez C,  Albanes D,  Virtamo J,  Weinstein S,  Schumacher FR,  Giovannucci E,  Willett WC,  Cussenot O,  Valeri A,  Andriole GL,  Crawford ED,  Tucker M,  Gerhard DS,  Fraumeni JF Jr,  Hoover R,  Hayes RB,  Hunter DJ,  Chanock SJ
Nat Genet 2008 Mar;40(3):310-5
PubMed ID: 18264096
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Latino recruitment to cancer prevention/screening trials in the Southwest: setting a research agenda.

Larkey LK,  Ogden SL,  Tenorio S,  Ewell T
Appl Nurs Res 2008 Feb;21(1):30-9
PubMed ID: 18226761
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Retrospective analysis of haplotype-based case control studies under a flexible model for gene environment association.

Chen YH,  Chatterjee N,  Carroll RJ
Biostatistics 2008 Jan;9(1):81-99
PubMed ID: 17490987
PMC ID: PMC2683243
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Estimating the cumulative risk of a false-positive under a regimen involving various types of cancer screening tests.

Baker SG,  Kramer BS
J Med Screen 2008;15(1):18-22
PubMed ID: 18416950
PMC ID: not available
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Genetic variation in sodium-dependent vitamin C transporters SLC23A1 and SLC23A2 and risk of advanced colorectal adenoma.

Erichsen HC,  Peters U,  Eck P,  Welch R,  Schoen RE,  Yeager M,  Levine M,  Hayes RB,  Chanock S
Nutr Cancer 2008;60(5):652-9
PubMed ID: 18791929
PMC ID: PMC3490215
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Dairy products, calcium intake, and risk of prostate cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.

Ahn J,  Albanes D,  Peters U,  Schatzkin A,  Lim U,  Freedman M,  Chatterjee N,  Andriole GL,  Leitzmann MF,  Hayes RB,  Prostate, Lung, Colorectal, and Ovarian Trial Project Team
Cancer Epidemiol Biomarkers Prev 2007 Dec;16(12):2623-30
PubMed ID: 18086766
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Fruit and vegetable intake and prevalence of colorectal adenoma in a cancer screening trial.

Millen AE,  Subar AF,  Graubard BI,  Peters U,  Hayes RB,  Weissfeld JL,  Yokochi LA,  Ziegler RG,  PLCO Cancer Screening Trial Project Team
Am J Clin Nutr 2007 Dec;86(6):1754-64
PubMed ID: 18065596
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

IGF-1 and IGFBP-3: Risk of prostate cancer among men in the Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Weiss JM,  Huang WY,  Rinaldi S,  Fears TR,  Chatterjee N,  Chia D,  Crawford ED,  Kaaks R,  Hayes RB
Int J Cancer 2007 Nov 15;121(10):2267-73
PubMed ID: 17597108
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Adherence to the USDA Food Guide, DASH Eating Plan, and Mediterranean dietary pattern reduces risk of colorectal adenoma.

Dixon LB,  Subar AF,  Peters U,  Weissfeld JL,  Bresalier RS,  Risch A,  Schatzkin A,  Hayes RB
J Nutr 2007 Nov;137(11):2443-50
PubMed ID: 17951483
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Polymorphic variants in alpha-methylacyl-CoA racemase and prostate cancer.

Daugherty SE,  Shugart YY,  Platz EA,  Fallin MD,  Isaacs WB,  Pfeiffer RM,  Welch R,  Huang WY,  Reding D,  Hayes RB
Prostate 2007 Oct 1;67(14):1487-97
PubMed ID: 17680641
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Sequence variants of estrogen receptor beta and risk of prostate cancer in the National Cancer Institute Breast and Prostate Cancer Cohort Consortium.

Chen YC,  Kraft P,  Bretsky P,  Ketkar S,  Hunter DJ,  Albanes D,  Altshuler D,  Andriole G,  Berg CD,  Boeing H,  Burtt N,  Bueno-de-Mesquita B,  Cann H,  Canzian F,  Chanock S,  Dunning A,  Feigelson HS,  Freedman M,  Gaziano JM,  Giovannucci E,  Sánchez MJ,  Haiman CA,  Hallmans G,  Hayes RB,  Henderson BE,  Hirschhorn J,  Kaaks R,  Key TJ,  Kolonel LN,  LeMarchand L,  Ma J,  Overvad K,  Palli D,  Pharaoh P,  Pike M,  Riboli E,  Rodriguez C,  Setiawan VW,  Stampfer M,  Stram DO,  Thomas G,  Thun MJ,  Travis RC,  Virtamo J,  Trichopoulou A,  Wacholder S,  Weinstein SJ
Cancer Epidemiol Biomarkers Prev 2007 Oct;16(10):1973-81
PubMed ID: 17932344
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Factors associated with human small aggressive non small cell lung cancer.

Tammemagi CM,  Freedman MT,  Church TR,  Oken MM,  Hocking WG,  Kvale PA,  Hu P,  Riley TL,  Ragard LR,  Prorok PC,  Berg CD
Cancer Epidemiol Biomarkers Prev 2007 Oct;16(10):2082-9
PubMed ID: 17932357
PMC ID: not available
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Transforming growth factor beta 1 (TGFB1) gene polymorphisms and risk of advanced colorectal adenoma.

Berndt SI,  Huang WY,  Chatterjee N,  Yeager M,  Welch R,  Chanock SJ,  Weissfeld JL,  Schoen RE,  Hayes RB
Carcinogenesis 2007 Sep;28(9):1965-70
PubMed ID: 17615257
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Variants in the alpha-Methylacyl-CoA racemase gene and the association with advanced distal colorectal adenoma.

Daugherty SE,  Platz EA,  Shugart YY,  Fallin MD,  Isaacs WB,  Chatterjee N,  Welch R,  Huang WY,  Hayes RB
Cancer Epidemiol Biomarkers Prev 2007 Aug;16(8):1536-42
PubMed ID: 17684125
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Functional variant of manganese superoxide dismutase (SOD2 V16A) polymorphism is associated with prostate cancer risk in the prostate, lung, colorectal, and ovarian cancer study.

Kang D,  Lee KM,  Park SK,  Berndt SI,  Peters U,  Reding D,  Chatterjee N,  Welch R,  Chanock S,  Huang WY,  Hayes RB
Cancer Epidemiol Biomarkers Prev 2007 Aug;16(8):1581-6
PubMed ID: 17646272
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Genetic variation in catechol-O-methyltransferase (COMT) and obesity in the prostate, lung, colorectal, and ovarian (PLCO) cancer screening trial.

Wang SS,  Morton LM,  Bergen AW,  Lan EZ,  Chatterjee N,  Kvale P,  Hayes RB,  Chanock SJ,  Caporaso NE
Hum Genet 2007 Aug;122(1):41-9
PubMed ID: 17497175
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

A genome-wide association study identifies alleles in FGFR2 associated with risk of sporadic postmenopausal breast cancer.

Hunter DJ,  Kraft P,  Jacobs KB,  Cox DG,  Yeager M,  Hankinson SE,  Wacholder S,  Wang Z,  Welch R,  Hutchinson A,  Wang J,  Yu K,  Chatterjee N,  Orr N,  Willett WC,  Colditz GA,  Ziegler RG,  Berg CD,  Buys SS,  McCarty CA,  Feigelson HS,  Calle EE,  Thun MJ,  Hayes RB,  Tucker M,  Gerhard DS,  Fraumeni JF Jr,  Hoover RN,  Thomas G,  Chanock SJ
Nat Genet 2007 Jul;39(7):870-4
PubMed ID: 17529973
PMC ID: PMC3493132
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

RNASEL Arg462Gln polymorphism and prostate cancer in PLCO.

Daugherty SE,  Hayes RB,  Yeager M,  Andriole GL,  Chatterjee N,  Huang WY,  Isaacs WB,  Platz EA
Prostate 2007 Jun 1;67(8):849-54
PubMed ID: 17407163
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Lack of association of transforming growth factor-beta1 polymorphisms and haplotypes with prostate cancer risk in the prostate, lung, colorectal, and ovarian trial.

Kang D,  Lee KM,  Park SK,  Berndt SI,  Reding D,  Chatterjee N,  Welch R,  Chanock S,  Huang WY,  Hayes RB
Cancer Epidemiol Biomarkers Prev 2007 Jun;16(6):1303-5
PubMed ID: 17548703
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Serum lycopene, other carotenoids, and prostate cancer risk: a nested case-control study in the prostate, lung, colorectal, and ovarian cancer screening trial.

Peters U,  Leitzmann MF,  Chatterjee N,  Wang Y,  Albanes D,  Gelmann EP,  Friesen MD,  Riboli E,  Hayes RB
Cancer Epidemiol Biomarkers Prev 2007 May;16(5):962-8
PubMed ID: 17507623
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Genome-wide association study of prostate cancer identifies a second risk locus at 8q24.

Yeager M,  Orr N,  Hayes RB,  Jacobs KB,  Kraft P,  Wacholder S,  Minichiello MJ,  Fearnhead P,  Yu K,  Chatterjee N,  Wang Z,  Welch R,  Staats BJ,  Calle EE,  Feigelson HS,  Thun MJ,  Rodriguez C,  Albanes D,  Virtamo J,  Weinstein S,  Schumacher FR,  Giovannucci E,  Willett WC,  Cancel-Tassin G,  Cussenot O,  Valeri A,  Andriole GL,  Gelmann EP,  Tucker M,  Gerhard DS,  Fraumeni JF Jr,  Hoover R,  Hunter DJ,  Chanock SJ,  Thomas G
Nat Genet 2007 May;39(5):645-9
PubMed ID: 17401363
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Prostate-specific antigen velocity and prostate cancer gleason grade and stage.

Pinsky PF,  Andriole G,  Crawford ED,  Chia D,  Kramer BS,  Grubb R,  Greenlee R,  Gohagan JK
Cancer 2007 Apr 15;109(8):1689-95
PubMed ID: 17330856
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Evidence of a healthy volunteer effect in the prostate, lung, colorectal, and ovarian cancer screening trial.

Pinsky PF,  Miller A,  Kramer BS,  Church T,  Reding D,  Prorok P,  Gelmann E,  Schoen RE,  Buys S,  Hayes RB,  Berg CD
Am J Epidemiol 2007 Apr 15;165(8):874-81
PubMed ID: 17244633
PMC ID: not available
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

A common 8q24 variant in prostate and breast cancer from a large nested case-control study.

Schumacher FR,  Feigelson HS,  Cox DG,  Haiman CA,  Albanes D,  Buring J,  Calle EE,  Chanock SJ,  Colditz GA,  Diver WR,  Dunning AM,  Freedman ML,  Gaziano JM,  Giovannucci E,  Hankinson SE,  Hayes RB,  Henderson BE,  Hoover RN,  Kaaks R,  Key T,  Kolonel LN,  Kraft P,  Le Marchand L,  Ma J,  Pike MC,  Riboli E,  Stampfer MJ,  Stram DO,  Thomas G,  Thun MJ,  Travis R,  Virtamo J,  Andriole G,  Gelmann E,  Willett WC,  Hunter DJ
Cancer Res 2007 Apr 1;67(7):2951-6
PubMed ID: 17409400
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Insulin resistance-related genes and advanced left-sided colorectal adenoma.

Gunter MJ,  Hayes RB,  Chatterjee N,  Yeager M,  Welch R,  Schoen RE,  Yakochi L,  Schatzkin A,  Peters U
Cancer Epidemiol Biomarkers Prev 2007 Apr;16(4):703-8
PubMed ID: 17416760
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Repeat prostate biopsy in the prostate, lung, colorectal and ovarian cancer screening trial.

Pinsky PF,  Crawford ED,  Kramer BS,  Andriole GL,  Gelmann EP,  Grubb R,  Greenlee R,  Gohagan JK
BJU Int 2007 Apr;99(4):775-9
PubMed ID: 17223921
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Lung cancer screening as a teachable moment for smoking cessation.

Taylor KL,  Cox LS,  Zincke N,  Mehta L,  McGuire C,  Gelmann E
Lung Cancer 2007 Apr;56(1):125-34
PubMed ID: 17196298
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Genetic variation in base excision repair genes and the prevalence of advanced colorectal adenoma.

Berndt SI,  Huang WY,  Fallin MD,  Helzlsouer KJ,  Platz EA,  Weissfeld JL,  Church TR,  Welch R,  Chanock SJ,  Hayes RB
Cancer Res 2007 Feb 1;67(3):1395-404
PubMed ID: 17283177
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Variant in sex hormone-binding globulin gene and the risk of prostate cancer.

Berndt SI,  Chatterjee N,  Huang WY,  Chanock SJ,  Welch R,  Crawford ED,  Hayes RB
Cancer Epidemiol Biomarkers Prev 2007 Jan;16(1):165-8
PubMed ID: 17220347
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Serum selenium and risk of prostate cancer-a nested case-control study.

Peters U,  Foster CB,  Chatterjee N,  Schatzkin A,  Reding D,  Andriole GL,  Crawford ED,  Sturup S,  Chanock SJ,  Hayes RB
Am J Clin Nutr 2007 Jan;85(1):209-17
PubMed ID: 17209198
PMC ID: PMC1839923
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Maximum Likelihood Inference on a Mixed Conditionally and Marginally Specified Regression Model for Genetic Epidemiologic Studies with Two-Phase Sampling

Chatterjee Nilanjan,  Chen Yi-Hau
J R Stat Soc 2007;69(2):123-142
PubMed ID: not available
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Powerful multilocus tests of genetic association in the presence of gene-gene and gene-environment interactions.

Chatterjee N,  Kalaylioglu Z,  Moslehi R,  Peters U,  Wacholder S
Am J Hum Genet 2006 Dec;79(6):1002-16
PubMed ID: 17186459
PMC ID: PMC1698705
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

DRD2 genetic variation in relation to smoking and obesity in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Morton LM,  Wang SS,  Bergen AW,  Chatterjee N,  Kvale P,  Welch R,  Yeager M,  Hayes RB,  Chanock SJ,  Caporaso NE
Pharmacogenet Genomics 2006 Dec;16(12):901-10
PubMed ID: 17108814
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Yield of advanced adenoma and cancer based on polyp size detected at screening flexible sigmoidoscopy.

Schoen RE,  Weissfeld JL,  Pinsky PF,  Riley T
Gastroenterology 2006 Dec;131(6):1683-9
PubMed ID: 17188959
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Carbohydrate, glycemic index, and glycemic load and colorectal adenomas in the Prostate, Lung, Colorectal, and Ovarian Screening Study.

Flood A,  Peters U,  Jenkins DJ,  Chatterjee N,  Subar AF,  Church TR,  Bresalier R,  Weissfeld JL,  Hayes RB,  Schatzkin A,  Prostate, Lung, Colorectal, Ovarian (PLCO) Project Team
Am J Clin Nutr 2006 Nov;84(5):1184-92
PubMed ID: 17093173
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Does a high folate intake increase the risk of breast cancer?

Kim YI
Nutr Rev 2006 Oct;64(10 Pt 1):468-75
PubMed ID: 17063929
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Abnormalities on chest radiograph reported in subjects in a cancer screening trial.

Pinsky PF,  Freedman M,  Kvale P,  Oken M,  Caporaso N,  Gohagan J
Chest 2006 Sep;130(3):688-93
PubMed ID: 16963664
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

A prospective study of dietary alpha-linolenic acid and the risk of prostate cancer (United States).

Koralek DO,  Peters U,  Andriole G,  Reding D,  Kirsh V,  Subar A,  Schatzkin A,  Hayes R,  Leitzmann MF
Cancer Causes Control 2006 Aug;17(6):783-91
PubMed ID: 16783606
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Prostate volume and prostate-specific antigen levels in men enrolled in a large screening trial.

Pinsky PF,  Kramer BS,  Crawford ED,  Grubb RL,  Urban DA,  Andriole GL,  Chia D,  Levin DL,  Gohagan JK
Urology 2006 Aug;68(2):352-6
PubMed ID: 16904451
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Ovarian volume: determinants and associations with cancer among postmenopausal women.

Sherman ME,  Lacey JV,  Buys SS,  Reding DJ,  Berg CD,  Williams C,  Hartge P
Cancer Epidemiol Biomarkers Prev 2006 Aug;15(8):1550-4
PubMed ID: 16896048
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Tobacco smoking and colorectal hyperplastic and adenomatous polyps.

Ji BT,  Weissfeld JL,  Chow WH,  Huang WY,  Schoen RE,  Hayes RB
Cancer Epidemiol Biomarkers Prev 2006 May;15(5):897-901
PubMed ID: 16702367
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Genetic polymorphisms of interleukin-1B (IL-1B), IL-6, IL-8, and IL-10 and risk of prostate cancer.

Michaud DS,  Daugherty SE,  Berndt SI,  Platz EA,  Yeager M,  Crawford ED,  Hsing A,  Huang WY,  Hayes RB
Cancer Res 2006 Apr 15;66(8):4525-30
PubMed ID: 16618781
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Prostate specific antigen changes as related to the initial prostate specific antigen: data from the prostate, lung, colorectal and ovarian cancer screening trial.

Crawford ED,  Pinsky PF,  Chia D,  Kramer BS,  Fagerstrom RM,  Andriole G,  Reding D,  Gelmann EP,  Levin DL,  Gohagan JK
J Urol 2006 Apr;175(4):1286-90; discussion 1290
PubMed ID: 16515981
PMC ID: not available
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Folate intake, alcohol use, and postmenopausal breast cancer risk in the Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial.

Stolzenberg-Solomon RZ,  Chang SC,  Leitzmann MF,  Johnson KA,  Johnson C,  Buys SS,  Hoover RN,  Ziegler RG
Am J Clin Nutr 2006 Apr;83(4):895-904
PubMed ID: 16600944
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Supplemental and dietary vitamin E, beta-carotene, and vitamin C intakes and prostate cancer risk.

Kirsh VA,  Hayes RB,  Mayne ST,  Chatterjee N,  Subar AF,  Dixon LB,  Albanes D,  Andriole GL,  Urban DA,  Peters U,  PLCO Trial
J Natl Cancer Inst 2006 Feb 15;98(4):245-54
PubMed ID: 16478743
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Association of energy intake and energy balance with postmenopausal breast cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.

Chang SC,  Ziegler RG,  Dunn B,  Stolzenberg-Solomon R,  Lacey JV Jr,  Huang WY,  Schatzkin A,  Reding D,  Hoover RN,  Hartge P,  Leitzmann MF
Cancer Epidemiol Biomarkers Prev 2006 Feb;15(2):334-41
PubMed ID: 16492925
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Nucleotide excision repair gene polymorphisms and risk of advanced colorectal adenoma: XPC polymorphisms modify smoking-related risk.

Huang WY,  Berndt SI,  Kang D,  Chatterjee N,  Chanock SJ,  Yeager M,  Welch R,  Bresalier RS,  Weissfeld JL,  Hayes RB
Cancer Epidemiol Biomarkers Prev 2006 Feb;15(2):306-11
PubMed ID: 16492920
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

High serum selenium and reduced risk of advanced colorectal adenoma in a colorectal cancer early detection program.

Peters U,  Chatterjee N,  Church TR,  Mayo C,  Sturup S,  Foster CB,  Schatzkin A,  Hayes RB
Cancer Epidemiol Biomarkers Prev 2006 Feb;15(2):315-20
PubMed ID: 16492922
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Effect of homeodomain protein NKX3.1 R52C polymorphism on prostate gland size.

Rodriguez Ortner E,  Hayes RB,  Weissfeld J,  Gelmann EP
Urology 2006 Feb;67(2):311-5
PubMed ID: 16442598
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

A prospective study of lycopene and tomato product intake and risk of prostate cancer.

Kirsh VA,  Mayne ST,  Peters U,  Chatterjee N,  Leitzmann MF,  Dixon LB,  Urban DA,  Crawford ED,  Hayes RB
Cancer Epidemiol Biomarkers Prev 2006 Jan;15(1):92-8
PubMed ID: 16434593
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Baseline chest radiograph for lung cancer detection in the randomized Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial.

Oken MM,  Marcus PM,  Hu P,  Beck TM,  Hocking W,  Kvale PA,  Cordes J,  Riley TL,  Winslow SD,  Peace S,  Levin DL,  Prorok PC,  Gohagan JK,  PLCO Project Team
J Natl Cancer Inst 2005 Dec 21;97(24):1832-9
PubMed ID: 16368945
PMC ID: not available
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

A prospective study of meat and meat mutagens and prostate cancer risk.

Cross AJ,  Peters U,  Kirsh VA,  Andriole GL,  Reding D,  Hayes RB,  Sinha R
Cancer Res 2005 Dec 15;65(24):11779-84
PubMed ID: 16357191
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Factors affecting older african american women's decisions to join the PLCO Cancer Screening Trial.

Trauth JM,  Jernigan JC,  Siminoff LA,  Musa D,  Neal-Ferguson D,  Weissfeld J
J Clin Oncol 2005 Dec 1;23(34):8730-8
PubMed ID: 16314633
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Ovarian cancer screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) cancer screening trial: findings from the initial screen of a randomized trial.

Buys SS,  Partridge E,  Greene MH,  Prorok PC,  Reding D,  Riley TL,  Hartge P,  Fagerstrom RM,  Ragard LR,  Chia D,  Izmirlian G,  Fouad M,  Johnson CC,  Gohagan JK,  PLCO Project Team
Am J Obstet Gynecol 2005 Nov;193(5):1630-9
PubMed ID: 16260202
PMC ID: not available
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Genetic variation in the HSD17B1 gene and risk of prostate cancer.

Kraft P,  Pharoah P,  Chanock SJ,  Albanes D,  Kolonel LN,  Hayes RB,  Altshuler D,  Andriole G,  Berg C,  Boeing H,  Burtt NP,  Bueno-de-Mesquita B,  Calle EE,  Cann H,  Canzian F,  Chen YC,  Crawford DE,  Dunning AM,  Feigelson HS,  Freedman ML,  Gaziano JM,  Giovannucci E,  Gonzalez CA,  Haiman CA,  Hallmans G,  Henderson BE,  Hirschhorn JN,  Hunter DJ,  Kaaks R,  Key T,  Le Marchand L,  Ma J,  Overvad K,  Palli D,  Pike MC,  Riboli E,  Rodriguez C,  Setiawan WV,  Stampfer MJ,  Stram DO,  Thomas G,  Thun MJ,  Travis R,  Trichopoulou A,  Virtamo J,  Wacholder S
PLoS Genet 2005 Nov;1(5):e68
PubMed ID: 16311626
PMC ID: PMC1287955
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Allellic variants in regulatory regions of cyclooxygenase-2: association with advanced colorectal adenoma.

Ali IU,  Luke BT,  Dean M,  Greenwald P
Br J Cancer 2005 Oct 17;93(8):953-9
PubMed ID: 16205694
PMC ID: PMC1369968
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Hormone replacement therapy, reproductive history, and colorectal adenomas: data from the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial (United States).

Purdue MP,  Mink PJ,  Hartge P,  Huang WY,  Buys S,  Hayes RB
Cancer Causes Control 2005 Oct;16(8):965-73
PubMed ID: 16132805
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Meat, meat cooking methods and preservation, and risk for colorectal adenoma.

Sinha R,  Peters U,  Cross AJ,  Kulldorff M,  Weissfeld JL,  Pinsky PF,  Rothman N,  Hayes RB
Cancer Res 2005 Sep 1;65(17):8034-41
PubMed ID: 16140978
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Variability in flexible sigmoidoscopy performance among examiners in a screening trial.

Pinsky PF,  Schoen RE,  Weissfeld JL,  Kramer B,  Hayes RB,  Yokochi L,  PLCO Project Team
Clin Gastroenterol Hepatol 2005 Aug;3(8):792-7
PubMed ID: 16234008
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Insulin-like growth factor-I and insulin are associated with the presence and advancement of adenomatous polyps.

Schoen RE,  Weissfeld JL,  Kuller LH,  Thaete FL,  Evans RW,  Hayes RB,  Rosen CJ
Gastroenterology 2005 Aug;129(2):464-75
PubMed ID: 16083703
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Flexible sigmoidoscopy in the PLCO cancer screening trial: results from the baseline screening examination of a randomized trial.

Weissfeld JL,  Schoen RE,  Pinsky PF,  Bresalier RS,  Church T,  Yurgalevitch S,  Austin JH,  Prorok PC,  Gohagan JK,  PLCO Project Team
J Natl Cancer Inst 2005 Jul 6;97(13):989-97
PubMed ID: 15998952
PMC ID: not available
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

GSTM1, GSTT1, and GSTP1 polymorphisms and risk of advanced colorectal adenoma.

Moore LE,  Huang WY,  Chatterjee N,  Gunter M,  Chanock S,  Yeager M,  Welch B,  Pinsky P,  Weissfeld J,  Hayes RB
Cancer Epidemiol Biomarkers Prev 2005 Jul;14(7):1823-7
PubMed ID: 16030123
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

CYP1A1 Val462 and NQO1 Ser187 polymorphisms, cigarette use, and risk for colorectal adenoma.

Hou L,  Chatterjee N,  Huang WY,  Baccarelli A,  Yadavalli S,  Yeager M,  Bresalier RS,  Chanock SJ,  Caporaso NE,  Ji BT,  Weissfeld JL,  Hayes RB
Carcinogenesis 2005 Jun;26(6):1122-8
PubMed ID: 15731166
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Associations of body mass index with meniscal tears.

Ford GM,  Hegmann KT,  White GL Jr,  Holmes EB
Am J Prev Med 2005 May;28(4):364-8
PubMed ID: 15831342
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Prostate Cancer Screening in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: findings from the initial screening round of a randomized trial.

Andriole GL,  Levin DL,  Crawford ED,  Gelmann EP,  Pinsky PF,  Chia D,  Kramer BS,  Reding D,  Church TR,  Grubb RL,  Izmirlian G,  Ragard LR,  Clapp JD,  Prorok PC,  Gohagan JK,  PLCO Project Team
J Natl Cancer Inst 2005 Mar 16;97(6):433-8
PubMed ID: 15770007
PMC ID: not available
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Prostate biopsy following a positive screen in the prostate, lung, colorectal and ovarian cancer screening trial.

Pinsky PF,  Andriole GL,  Kramer BS,  Hayes RB,  Prorok PC,  Gohagan JK,  Prostate, Lung, Colorectal and Ovarian Project Team
J Urol 2005 Mar;173(3):746-1
PubMed ID: 15711261
PMC ID: not available
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Development and application of a simple routine method for the determination of selenium in serum by octopole reaction system ICPMS.

Stürup S,  Hayes RB,  Peters U
Anal Bioanal Chem 2005 Feb;381(3):686-94
PubMed ID: 15702311
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Effects of false-positive prostate cancer screening results on subsequent prostate cancer screening behavior.

Ford ME,  Havstad SL,  Demers R,  Cole Johnson C
Cancer Epidemiol Biomarkers Prev 2005 Jan;14(1):190-4
PubMed ID: 15668495
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Microsomal epoxide hydrolase polymorphisms and risk for advanced colorectal adenoma.

Huang WY,  Chatterjee N,  Chanock S,  Dean M,  Yeager M,  Schoen RE,  Hou LF,  Berndt SI,  Yadavalli S,  Johnson CC,  Hayes RB
Cancer Epidemiol Biomarkers Prev 2005 Jan;14(1):152-7
PubMed ID: 15668489
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Hemochromatosis gene mutations and distal adenomatous colorectal polyps.

McGlynn KA,  Sakoda LC,  Hu Y,  Schoen RE,  Bresalier RS,  Yeager M,  Chanock S,  Hayes RB,  Buetow KH
Cancer Epidemiol Biomarkers Prev 2005 Jan;14(1):158-63
PubMed ID: 15668490
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

The economic impact of false-positive cancer screens.

Lafata JE,  Simpkins J,  Lamerato L,  Poisson L,  Divine G,  Johnson CC
Cancer Epidemiol Biomarkers Prev 2004 Dec;13(12):2126-32
PubMed ID: 15598770
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Association of genetic variants in the calcium-sensing receptor with risk of colorectal adenoma.

Peters U,  Chatterjee N,  Yeager M,  Chanock SJ,  Schoen RE,  McGlynn KA,  Church TR,  Weissfeld JL,  Schatzkin A,  Hayes RB
Cancer Epidemiol Biomarkers Prev 2004 Dec;13(12):2181-6
PubMed ID: 15598778
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Design of a case management approach to enhance cancer screening trial retention among older African American men.

Ford ME,  Randolph V,  Hopkins-Johnson L,  Eason SL,  Havstad S,  Jankowski M,  Swanson GM,  Johnson CC,  Vernon SW
J Aging Health 2004 Nov;16(5 Suppl):39S-57S
PubMed ID: 15448286
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Calcium intake and colorectal adenoma in a US colorectal cancer early detection program.

Peters U,  Chatterjee N,  McGlynn KA,  Schoen RE,  Church TR,  Bresalier RS,  Gaudet MM,  Flood A,  Schatzkin A,  Hayes RB
Am J Clin Nutr 2004 Nov;80(5):1358-65
PubMed ID: 15531687
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

False-positive cancer screens and health-related quality of life.

McGovern PM,  Gross CR,  Krueger RA,  Engelhard DA,  Cordes JE,  Church TR
Cancer Nurs 2004 Sep-Oct;27(5):347-52
PubMed ID: 15525861
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Transvaginal ultrasound measurement of endometrial thickness as a biomarker for estrogen exposure.

Sit AS,  Modugno F,  Hill LM,  Martin J,  Weissfeld JL
Cancer Epidemiol Biomarkers Prev 2004 Sep;13(9):1459-65
PubMed ID: 15342446
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Quality of life and trial adherence among participants in the prostate, lung, colorectal, and ovarian cancer screening trial.

Taylor KL,  Shelby R,  Gelmann E,  McGuire C
J Natl Cancer Inst 2004 Jul 21;96(14):1083-94
PubMed ID: 15265970
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

The prostate, lung, colon, and ovarian (PLCO) cancer screening trial: Status and promise.

Andriole GL,  Reding D,  Hayes RB,  Prorok PC,  Gohagan JK,  PLCO Steering Committee
Urol Oncol 2004 Jul-Aug;22(4):358-61
PubMed ID: 15283897
PMC ID: not available
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Risk behaviours and benign prostatic hyperplasia.

Kang D,  Andriole GL,  Van De Vooren RC,  Crawford D,  Chia D,  Urban DA,  Reding D,  Huang WY,  Hayes RB
BJU Int 2004 Jun;93(9):1241-5
PubMed ID: 15180615
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

The Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: biopsy rates and cancer characteristics of initial (T0) screen

Andriole GL,  Pinsk PF,  Levin DL,  Gelmann EP,  Crawford ED,  Reding DJ,  Prorok PC,  Gohagan JK
J Urol 2004 Apr;171(4):473-473 Suppl S
PubMed ID: not available
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Circulating vitamin D metabolites, polymorphism in vitamin D receptor, and colorectal adenoma risk.

Peters U,  Hayes RB,  Chatterjee N,  Shao W,  Schoen RE,  Pinsky P,  Hollis BW,  McGlynn KA,  Prostate, Lung, Colorectal and Ovarian Cancer Screening Project Team
Cancer Epidemiol Biomarkers Prev 2004 Apr;13(4):546-52
PubMed ID: 15066918
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Associations between body-mass index and surgery for rotator cuff tendinitis.

Wendelboe AM,  Hegmann KT,  Gren LH,  Alder SC,  White GL Jr,  Lyon JL
J Bone Joint Surg Am 2004 Apr;86-A(4):743-7
PubMed ID: 15069138
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

A randomized trial of recruitment methods for older African American men in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Ford ME,  Havstad SL,  Davis SD
Clin Trials 2004;1(4):343-51
PubMed ID: 16279272
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Results of repeat sigmoidoscopy 3 years after a negative examination.

Schoen RE,  Pinsky PF,  Weissfeld JL,  Bresalier RS,  Church T,  Prorok P,  Gohagan JK,  Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Group
JAMA 2003 Jul 2;290(1):41-8
PubMed ID: 12837710
PMC ID: not available
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Dietary fibre and colorectal adenoma in a colorectal cancer early detection programme.

Peters U,  Sinha R,  Chatterjee N,  Subar AF,  Ziegler RG,  Kulldorff M,  Bresalier R,  Weissfeld JL,  Flood A,  Schatzkin A,  Hayes RB,  Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Project Team
Lancet 2003 May 3;361(9368):1491-5
PubMed ID: 12737857
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Reported family history of cancer in the prostate, lung, colorectal, and ovarian cancer screening trial.

Pinsky PF,  Kramer BS,  Reding D,  Buys S,  PLCO Project Team
Am J Epidemiol 2003 May 1;157(9):792-9
PubMed ID: 12727673
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Predictors of advanced proximal neoplasia in persons with abnormal screening flexible sigmoidoscopy.

Pinsky PF,  Schoen RE,  Weissfeld JL,  Bresalier RS,  Hayes RB,  Gohagan JK
Clin Gastroenterol Hepatol 2003 Mar;1(2):103-10
PubMed ID: 15017502
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Patient preferences for CT colonography, conventional colonoscopy, and bowel preparation.

Ristvedt SL,  McFarland EG,  Weinstock LB,  Thyssen EP
Am J Gastroenterol 2003 Mar;98(3):578-85
PubMed ID: 12650790
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Recruiting older African American men to a cancer screening trial (the AAMEN Project).

Ford ME,  Havstad SL,  Tilley BC
Gerontologist 2003 Feb;43(1):27-35
PubMed ID: 12604743
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Examining the effects of false positive lung cancer screening results on subsequent lung cancer screening adherence.

Ford ME,  Havstad SL,  Flickinger L,  Johnson CC
Cancer Epidemiol Biomarkers Prev 2003 Jan;12(1):28-33
PubMed ID: 12540500
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Whole blood cryopreservation in epidemiological studies.

Hayes RB,  Smith CO,  Huang WY,  Read Y,  Kopp WC
Cancer Epidemiol Biomarkers Prev 2002 Nov;11(11):1496-8
PubMed ID: 12433734
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

CT colonography: multiobserver diagnostic performance.

McFarland EG,  Pilgram TK,  Brink JA,  McDermott RA,  Santillan CV,  Brady PW,  Heiken JP,  Balfe DM,  Weinstock LB,  Thyssen EP,  Littenberg B
Radiology 2002 Nov;225(2):380-90
PubMed ID: 12409570
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

The impact of item order on ratings of cancer risk perception.

Taylor KL,  Shelby RA,  Schwartz MD,  Ackerman J,  LaSalle VH,  Gelmann EP,  McGuire C
Cancer Epidemiol Biomarkers Prev 2002 Jul;11(7):654-9
PubMed ID: 12101113
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Lack of association between adipose tissue distribution and IGF-1 and IGFBP-3 in men and women.

Schoen RE,  Schragin J,  Weissfeld JL,  Thaete FL,  Evans RW,  Rosen CJ,  Kuller LH
Cancer Epidemiol Biomarkers Prev 2002 Jun;11(6):581-6
PubMed ID: 12050100
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Adherence to repeat screening flexible sigmoidoscopy in the Prostate, Lung, Colorectal, and Ovarian (PLCO) Cancer Screening Trial.

Weissfeld JL,  Ling BS,  Schoen RE,  Bresalier RS,  Riley T,  Prorok PC,  Prostate, Lung, Colorectal, and Ovarian Project Team
Cancer 2002 May 15;94(10):2569-76
PubMed ID: 12173322
PMC ID: not available
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Large-scale randomized prostate cancer screening trials: program performances in the European Randomized Screening for Prostate Cancer trial and the Prostate, Lung, Colorectal and Ovary cancer trial.

de Koning HJ,  Auvinen A,  Berenguer Sanchez A,  Calais da Silva F,  Ciatto S,  Denis L,  Gohagan JK,  Hakama M,  Hugosson J,  Kranse R,  Nelen V,  Prorok PC,  Schröder FH,  European Randomized Screening for Prostate Cancer (ERSPC) Trial,  International Prostate Cancer Screening Trials Evaluation Group
Int J Cancer 2002 Jan 10;97(2):237-44
PubMed ID: 11774270
PMC ID: not available
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Health-related quality of life and cost-effectiveness studies in the European randomised study of screening for prostate cancer and the US Prostate, Lung, Colon and Ovary trial.

Miller AB,  Madalinska JB,  Church T,  Crawford D,  Essink-Bot ML,  Goel V,  de Koning HJ,  Määttänen L,  Pentikäinen T
Eur J Cancer 2001 Nov;37(17):2154-60
PubMed ID: 11677101
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Relationship of demographic and clinical factors to free and total prostate-specific antigen.

Gelmann EP,  Chia D,  Pinsky PF,  Andriole GL,  Crawford ED,  Reding D,  Hayes RB,  Kramer BS,  Woodrum DL,  Gohagan JK,  Levin DL,  PLCO Screening Trial Investigators
Urology 2001 Oct;58(4):561-6
PubMed ID: 11597539
PMC ID: not available
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Estimation and prediction for cancer screening models using deconvolution and smoothing.

Pinsky PF
Biometrics 2001 Jun;57(2):389-95
PubMed ID: 11414561
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Is shorter always better? Relative importance of questionnaire length and cognitive ease on response rates and data quality for two dietary questionnaires.

Subar AF,  Ziegler RG,  Thompson FE,  Johnson CC,  Weissfeld JL,  Reding D,  Kavounis KH,  Hayes RB,  Prostate, Lung, Colorectal, and Ovarian Cancer Screening Trial Investigators
Am J Epidemiol 2001 Feb 15;153(4):404-9
PubMed ID: 11207159
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Spiral CT colonography: reader agreement and diagnostic performance with two- and three-dimensional image-display techniques.

McFarland EG,  Brink JA,  Pilgram TK,  Heiken JP,  Balfe DM,  Hirselj DA,  Weinstock L,  Littenberg B
Radiology 2001 Feb;218(2):375-83
PubMed ID: 11161149
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Design and evolution of the data management systems in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Hasson MA,  Fagerstrom RM,  Kahane DC,  Walsh JH,  Myers MH,  Caughman C,  Wenzel B,  Haralson JC,  Flickinger LM,  Turner LM,  Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team
Control Clin Trials 2000 Dec;21(6 Suppl):329S-348S
PubMed ID: 11189686
PMC ID: not available
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Etiologic and early marker studies in the prostate, lung, colorectal and ovarian (PLCO) cancer screening trial.

Hayes RB,  Reding D,  Kopp W,  Subar AF,  Bhat N,  Rothman N,  Caporaso N,  Ziegler RG,  Johnson CC,  Weissfeld JL,  Hoover RN,  Hartge P,  Palace C,  Gohagan JK,  Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team
Control Clin Trials 2000 Dec;21(6 Suppl):349S-355S
PubMed ID: 11189687
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Death review process in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Miller AB,  Yurgalevitch S,  Weissfeld JL,  Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team
Control Clin Trials 2000 Dec;21(6 Suppl):400S-406S
PubMed ID: 11189691
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Coordination and management of a large multicenter screening trial: the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

O'Brien B,  Nichaman L,  Browne JE,  Levin DL,  Prorok PC,  Gohagan JK,  Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team
Control Clin Trials 2000 Dec;21(6 Suppl):310S-328S
PubMed ID: 11189685
PMC ID: not available
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Design of the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Prorok PC,  Andriole GL,  Bresalier RS,  Buys SS,  Chia D,  Crawford ED,  Fogel R,  Gelmann EP,  Gilbert F,  Hasson MA,  Hayes RB,  Johnson CC,  Mandel JS,  Oberman A,  O'Brien B,  Oken MM,  Rafla S,  Reding D,  Rutt W,  Weissfeld JL,  Yokochi L,  Gohagan JK,  Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team
Control Clin Trials 2000 Dec;21(6 Suppl):273S-309S
PubMed ID: 11189684
PMC ID: not available
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Recruitment strategies in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial: the first six years.

Simpson NK,  Johnson CC,  Ogden SL,  Gamito E,  Trocky N,  McGuire C,  Martin J,  Barrow S,  Lamerato L,  Flickinger LM,  Broski KG,  Engelhard D,  Hilke C,  Bonk J,  Gahagan B,  Gren LH,  Childs J,  Lappe K,  Fouad M,  Thompson J,  Sullivan D,  Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team
Control Clin Trials 2000 Dec;21(6 Suppl):356S-378S
PubMed ID: 11189688
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Black participation in the Prostate, Lung, Colorectal and Ovarian (PLCO) Cancer Screening Trial.

Stallings FL,  Ford ME,  Simpson NK,  Fouad M,  Jernigan JC,  Trauth JM,  Miller DS,  Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial Project Team
Control Clin Trials 2000 Dec;21(6 Suppl):379S-389S
PubMed ID: 11189689
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Complex ovarian cysts in postmenopausal women are not associated with ovarian cancer risk factors: preliminary data from the prostate, lung, colon, and ovarian cancer screening trial.

Hartge P,  Hayes R,  Reding D,  Sherman ME,  Prorok P,  Schiffman M,  Buys S
Am J Obstet Gynecol 2000 Nov;183(5):1232-7
PubMed ID: 11084571
PMC ID: not available
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

Influence of image acquisition parameters on CT artifacts and polyp depiction in spiral CT colonography: in vitro evaluation.

Whiting BR,  McFarland EG,  Brink JA
Radiology 2000 Oct;217(1):165-72
PubMed ID: 11012440
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Patient satisfaction with screening flexible sigmoidoscopy.

Schoen RE,  Weissfeld JL,  Bowen NJ,  Switzer G,  Baum A
Arch Intern Med 2000 Jun 26;160(12):1790-6
PubMed ID: 10871972
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Helical CT colonography (virtual colonoscopy): the challenge that exists between advancing technology and generalizability.

McFarland EG,  Brink JA
AJR Am J Roentgenol 1999 Sep;173(3):549-59
PubMed ID: 10470878
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Rationale for randomised trials of prostate cancer screening. The International Prostate Screening Trial Evaluation Group.

The International Prostate Screening Trial Evaluation Group,  Alexander FE,  Andriole GL,  Aus G,  Auvinen A,  Beensterboer P,  Blijenberg BG,  Bonardi R,  Buys S,  Canda B,  Ciatto S,  Crawford ED,  Demers R,  de Koning HJ,  Denis L,  Dijk MA,  Figueiredo F,  Gellman EP,  Gohagan J,  Hakama M,  Hugosson J,  Kirkels WI,  Kranse R,  van der Kwast TH,  Lilja H,  Määttänen L,  Mandel J,  Miller AB,  Monteiro H,  Nelen V,  Oberman A,  Paez A,  Prorok PC,  Reding D,  Rietbergen JWBW,  Rose DB,  Sanchez AB,  Schröder FH,  da Silva EC,  Simpson N,  Smith PH,  Stadaert B,  Stenman UH,  Teppo L,  Turkes A,  Weissfeld JL,  Yokochi L
Eur J Cancer 1999 Feb;35(2):262-71
PubMed ID: 10448269
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Recruiting black men to a clinical trial to evaluate prostate cancer screening--Detroit, Michigan, 1998.

Centers for Disease Control and Prevention (CDC)
MMWR Morb Mortal Wkly Rep 1998 Aug 28;47(33):694-6
PubMed ID: 9733417
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Screening and prevention trials step up minority recruitment.

Reynolds T
J Natl Cancer Inst 1996 Sep 18;88(18):1265-7
PubMed ID: 8797765
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Prospective evaluation plan for randomised trials of prostate cancer screening. The International Prostate Cancer Screening Trial Evaluation Group.

Auvinen A,  Rietbergen JB,  Denis LJ,  Schröder FH,  Prorok PC
J Med Screen 1996;3(2):97-104
PubMed ID: 8849769
PMC ID: not available
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

The Prostate, Lung, Colorectal and Ovarian Cancer Screening Trial of the National Cancer Institute.

Gohagan JK,  Prorok PC,  Kramer BS,  Hayes RB,  Cornett JE
Cancer 1995 Apr 1;75(Suppl S7):1869-1873
PubMed ID: not available
PMC ID: not available
Groups or Programs: BiometryPLCO Cancer Screening TrialEarly Detection

NIH Consensus 1994: screening.

Kramer BS,  Gohagan J,  Prorok PC
Gynecol Oncol 1994 Dec;55(3 Pt 2):S20-1
PubMed ID: 7835804
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Prostate cancer screening in the prostate, lung, colorectal and ovarian cancer screening trial of the National Cancer Institute.

Gohagan JK,  Prorok PC,  Kramer BS,  Cornett JE
J Urol 1994 Nov;152(5 Pt 2):1905-9
PubMed ID: 7523735
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

The National Cancer Institute Multi-Screening Trial.

Prorok P
Can J Oncol 1994 Nov;4 Suppl 1:98-1
PubMed ID: 8853500
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

"Screening for prostate cancer".

Gohagan JK,  Kramer BS,  Greenwald P
Am J Prev Med 1994 Jul-Aug;10(4):245-6
PubMed ID: 7528519
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial

Prostate cancer screening: what we know and what we need to know.

Kramer BS,  Brown ML,  Prorok PC,  Potosky AL,  Gohagan JK
Ann Intern Med 1993 Nov 1;119(9):914-23
PubMed ID: 7692780
PMC ID: not available
Groups or Programs: Early DetectionBiometryPLCO Cancer Screening Trial

A National Cancer Institute sponsored screening trial for prostatic, lung, colorectal, and ovarian cancers.

Kramer BS,  Gohagan J,  Prorok PC,  Smart C
Cancer 1993 Jan 15;71(2 Suppl):589-93
PubMed ID: 8420681
PMC ID: not available
Groups or Programs: Early DetectionPLCO Cancer Screening Trial